Amedeo Smart

Free Medical Literature Service


 

Amedeo

Liver Diseases

  Free Subscription

Articles published in
Dig Dis Sci
    September 2021
  1. KONG J, Liang X, Zhang J, Zeng J, et al
    Antiviral Therapy Improves Survival in Hepatocellular Carcinoma with Microvascular Invasion: A Propensity Score Analysis.
    Dig Dis Sci. 2021 Sep 14. pii: 10.1007/s10620-021-07248.
    >> Share

    August 2021
  2. YOPES MC, Mozeika AM, Liebling S, Haslam A, et al
    An Analysis of 5 Years of Randomized Trials in Gastroenterology and Hepatology Reveals 52 Medical Reversals.
    Dig Dis Sci. 2021 Aug 31. pii: 10.1007/s10620-021-07199.
    >> Share

  3. HANSEN L, Chang MF, Hiatt S, Dieckmann NF, et al
    Symptom Frequency and Distress Underestimated in Decompensated Cirrhosis.
    Dig Dis Sci. 2021 Aug 27. pii: 10.1007/s10620-021-07216.
    >> Share

  4. LOUISSAINT J, Kassab I, Yeboah-Korang A, Fontana RJ, et al
    Combining K-72 Hepatic Failure with 15 Individual T-Codes to Identify Patients with Idiosyncratic Drug-Induced Liver Injury in the Electronic Medical Record.
    Dig Dis Sci. 2021 Aug 24. pii: 10.1007/s10620-021-07223.
    >> Share

  5. TRIVEDI HD, Niezen S, Jiang ZG, Tapper EB, et al
    Severe Hepatic Steatosis by Controlled Attenuation Parameter Predicts Quality of Life Independent of Fibrosis.
    Dig Dis Sci. 2021 Aug 21. pii: 10.1007/s10620-021-07228.
    >> Share

  6. VIJAYARAGHAVAN R, Maiwall R, Arora V, Choudhary A, et al
    Reversal of Feed Intolerance by Prokinetics Improves Survival in Critically Ill Cirrhosis Patients.
    Dig Dis Sci. 2021 Aug 14. pii: 10.1007/s10620-021-07185.
    >> Share

  7. CHEN Y, Li H, Chen D, Jiang X, et al
    Hypoxic Hepatocellular Carcinoma Cells Acquire Arsenic Trioxide Resistance by Upregulating HIF-1alpha Expression.
    Dig Dis Sci. 2021 Aug 12. pii: 10.1007/s10620-021-07202.
    >> Share

  8. THAKER S, Mikolajczyk AE
    Concise Commentary: Are We Making a Difference? The Impact of Inpatient Gastroenterology and Hepatology Consultations for Cirrhotic Patients.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07171.
    >> Share

  9. SERPER M, Kaplan DE, Lin M, Taddei TH, et al
    Inpatient Gastroenterology Consultation and Outcomes of Cirrhosis-Related Hospitalizations in Two Large National Cohorts.
    Dig Dis Sci. 2021 Aug 10. pii: 10.1007/s10620-021-07150.
    >> Share

    July 2021
  10. BOCKORNY B, Bullock AJ, Abrams TA, Faintuch S, et al
    Priming of Sorafenib Prior to Radiofrequency Ablation Does Not Increase Treatment Effect in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jul 23. pii: 10.1007/s10620-021-07156.
    >> Share

  11. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    >> Share

  12. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    >> Share

  13. BARNES EL, Grimm-Vavlitis JL, Long MD
    Impact of Virtual Interviews on Gastroenterology and Hepatology Fellowship Recruitment.
    Dig Dis Sci. 2021 Jul 15. pii: 10.1007/s10620-021-07123.
    >> Share

  14. LIU J, He X, Zou Y, Wang K, et al
    Circular RNA Circ-STIL Contributes to Cell Growth and Metastasis in Hepatocellular Carcinoma via Regulating miR-345-5p/AQP3 Axis.
    Dig Dis Sci. 2021 Jul 6. pii: 10.1007/s10620-021-07054.
    >> Share

  15. MANKA P, Syn WK
    NASH, Metabolic Syndrome, and Diabetes: How Sugar and Fat Increase the Risk of Developing Advanced Liver Disease.
    Dig Dis Sci. 2021;66:2147-2148.
    >> Share

  16. BOPPANA V, Sahni S, Glass J, Chang C, et al
    HCC You Cannot See.
    Dig Dis Sci. 2021;66:2185-2189.
    >> Share

  17. MARTIN M, Zou B, Hoang J, Jeong D, et al
    Racial and Socioeconomic Disparities in Hospitalization of Pediatrics with Liver Disease from 2005 to 2015.
    Dig Dis Sci. 2021;66:2240-2249.
    >> Share

    June 2021
  18. DELEURAN T, Watson H, Vilstrup H, Jepsen P, et al
    Risk Factors for Hepatic Hydrothorax in Cirrhosis Patients with Ascites - A Clinical Cohort Study.
    Dig Dis Sci. 2021 Jun 30. pii: 10.1007/s10620-021-07134.
    >> Share

  19. ZHOU K, Dodge JL, Yuan L, Terrault NA, et al
    Metabolic Risk Profiles for Hepatic Steatosis Differ by Race/Ethnicity: An Elastography-Based Study of US Adults.
    Dig Dis Sci. 2021 Jun 26. pii: 10.1007/s10620-021-07124.
    >> Share

  20. FRENETTE CT, Levy C, Saab S
    Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
    Dig Dis Sci. 2021 Jun 24. pii: 10.1007/s10620-021-07075.
    >> Share

  21. HA NB, Cho SJ, Mohamad Y, Kent D, et al
    Visceral Adipose Tissue Inflammation and Radiographic Visceral-to-Subcutaneous Adipose Tissue Ratio in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jun 16. pii: 10.1007/s10620-021-07099.
    >> Share

  22. DAHIYA M, Eboreime E, Hyde A, Rahman S, et al
    International Classification of Diseases Codes are Useful in Identifying Cirrhosis in Administrative Databases.
    Dig Dis Sci. 2021 Jun 6. pii: 10.1007/s10620-021-07076.
    >> Share

  23. ZOU B, Yeo YH, Cheung R, Ingelsson E, et al
    Fatty Liver Index and Development of Cardiovascular Disease: Findings from the UK Biobank.
    Dig Dis Sci. 2021;66:2092-2100.
    >> Share

  24. SHARMA A, Keshava SN, Eapen A, Elias E, et al
    An Update on the Management of Budd-Chiari Syndrome.
    Dig Dis Sci. 2021;66:1780-1790.
    >> Share

    May 2021
  25. PENG X, Tian A, Li J, Mao Y, et al
    Diagnostic Value of FibroTouch and Non-invasive Fibrosis Indexes in Hepatic Fibrosis with Different Aetiologies.
    Dig Dis Sci. 2021 May 31. pii: 10.1007/s10620-021-07049.
    >> Share

  26. CACCAMO G, Franze MS, Saffioti F, Pitrone C, et al
    Cirrhotic Patients with Bacterial Infection and Negative Cultures Have a More Advanced Disease and an Increased Short-Term Mortality Rate.
    Dig Dis Sci. 2021 May 26. pii: 10.1007/s10620-021-07047.
    >> Share

  27. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    >> Share

  28. LI X, Lv J, Hou L, Guo X, et al
    Circ_0001955 Acts as a miR-646 Sponge to Promote the Proliferation, Metastasis and Angiogenesis of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 22. pii: 10.1007/s10620-021-07053.
    >> Share

  29. SERPER M
    Monitoring for Ascites in Cirrhosis Using Patient-Generated Health Data: No Longer a Remote Possibility.
    Dig Dis Sci. 2021 May 18. pii: 10.1007/s10620-021-07020.
    >> Share

  30. YU B, Zhou S, Liang H, Ye Q, et al
    Development and Validation of a Novel Circulating miRNA-Based Diagnostic Score for Early Detection of Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 May 12. pii: 10.1007/s10620-021-07031.
    >> Share

  31. BLOOM PP, Ventoso M, Tapper E, Ha J, et al
    A Telemonitoring Intervention for Cirrhotic Ascites Management Is Cost-Saving.
    Dig Dis Sci. 2021 May 6. pii: 10.1007/s10620-021-07013.
    >> Share

  32. TO C, Liu L, Satoskar RS, Thuluvath PJ, et al
    Diabetic Hepatosclerosis in a Woman with Maturity-Onset Diabetes of the Young Type 3.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07005.
    >> Share

  33. RICH NE, Parvathaneni A, Sen A, Odewole M, et al
    High Neutrophil-Lymphocyte Ratio and Delta Neutrophil-Lymphocyte Ratio Are Associated with Increased Mortality in Patients with Hepatocellular Cancer.
    Dig Dis Sci. 2021 May 3. pii: 10.1007/s10620-021-07001.
    >> Share

  34. HASHIMOTO R, Lee DP, Samarasena JB, Chandan VS, et al
    Comparison of Two Specialized Histology Needles for Endoscopic Ultrasound (EUS)-Guided Liver Biopsy: A Pilot Study.
    Dig Dis Sci. 2021;66:1700-1706.
    >> Share

    April 2021
  35. SCHEWE J, Makeschin MC, Khandoga A, Zhang J, et al
    To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning.
    Dig Dis Sci. 2021;66:1349-1359.
    >> Share

  36. TROWELL J, Alukal J, Zhang T, Liu L, et al
    How Good Are Controlled Attenuation Parameter Scores from Fibroscan to Assess Steatosis, NASH, and Fibrosis?
    Dig Dis Sci. 2021;66:1297-1305.
    >> Share

  37. SINGAL AK, Ahmed Z, Axley P, Arora S, et al
    Hospitalizations for Acute on Chronic Liver Failure at Academic Compared to Non-academic Centers Have Higher Mortality.
    Dig Dis Sci. 2021;66:1306-1314.
    >> Share

    March 2021
  38. LIN RX, Zhan GF, Wu JC, Fang H, et al
    LncRNA SNHG14 Sponges miR-206 to Affect Proliferation, Apoptosis, and Metastasis of Hepatocellular Carcinoma Cells by Regulating SOX9.
    Dig Dis Sci. 2021 Mar 29. pii: 10.1007/s10620-021-06920.
    >> Share

  39. MAHMUD N, Asrani SK, Reese PP, Kaplan DE, et al
    Race Adjustment in eGFR Equations Does Not Improve Estimation of Acute Kidney Injury Events in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Mar 24. pii: 10.1007/s10620-021-06943.
    >> Share

  40. LIN K, Huang Q, Zeng J, Ding Z, et al
    Clinical Significance of Alpha-Fetoprotein in Alpha-Fetoprotein Negative Hepatocellular Carcinoma Underwent Curative Resection.
    Dig Dis Sci. 2021 Mar 16. pii: 10.1007/s10620-020-06797.
    >> Share

  41. PERISETTI A, Goyal H
    Successful Distancing: Telemedicine in Gastroenterology and Hepatology During the COVID-19 Pandemic.
    Dig Dis Sci. 2021 Mar 3. pii: 10.1007/s10620-021-06874.
    >> Share

    February 2021
  42. MIRAGLIA R, Maruzzelli L, Luca A
    Transjugular Intrahepatic Portosystemic Shunt: A Single-Centre Mid-term Experience Using the Viatorr Controlled-Expansion Stent.
    Dig Dis Sci. 2021 Feb 27. pii: 10.1007/s10620-021-06867.
    >> Share

  43. WANG X, Luo X, Yang L
    Risk Factors for Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt: Beyond Stent Diameter.
    Dig Dis Sci. 2021 Feb 26. pii: 10.1007/s10620-021-06868.
    >> Share

  44. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    >> Share

  45. XU YP, Dong ZN, Zhou YQ, Zhao YJ, et al
    Role of eIF3C Overexpression in Predicting Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2021 Feb 12. pii: 10.1007/s10620-021-06878.
    >> Share

  46. CHEN YC, Hsu CW, Jeng WJ, Lin CY, et al
    Advanced Liver Fibrosis Is Associated with Necroinflammatory Grade but Not Hepatic Steatosis in Chronic Hepatitis B Patients.
    Dig Dis Sci. 2021 Feb 10. pii: 10.1007/s10620-020-06761.
    >> Share

  47. BIE C, Chen Y, Tang H, Li Q, et al
    Insulin-Like Growth Factor 1 Receptor Drives Hepatocellular Carcinoma Growth and Invasion by Activating Stat3-Midkine-Stat3 Loop.
    Dig Dis Sci. 2021 Feb 9. pii: 10.1007/s10620-021-06862.
    >> Share

  48. STERLING RK, King WC, Khalili M, Kleiner DE, et al
    Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected Adults.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06860.
    >> Share

  49. ZHANG D, Zhang Y, Zhang X, Zhai H, et al
    Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Dig Dis Sci. 2021 Feb 8. pii: 10.1007/s10620-021-06861.
    >> Share

  50. NAM JY, Lee YB, Lee JH, Yu SJ, et al
    A Prognostic Prediction Model of Transarterial Radioembolization in Hepatocellular Carcinoma: SNAP-HCC.
    Dig Dis Sci. 2021 Feb 4. pii: 10.1007/s10620-021-06843.
    >> Share

  51. ZHOU SN, Pan WT, Pan MX, Luo QY, et al
    Comparison of Immune Microenvironment Between Colon and Liver Metastatic Tissue in Colon Cancer Patients with Liver Metastasis.
    Dig Dis Sci. 2021;66:474-482.
    >> Share

  52. PATIDAR KR, Davis BC, Slaven JE, Ghabril MS, et al
    Admission Factor V Predicts Transplant-Free Survival in Acute Liver Failure.
    Dig Dis Sci. 2021;66:619-627.
    >> Share

    January 2021
  53. WU M, Jiang L
    Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
    Dig Dis Sci. 2021 Jan 26. pii: 10.1007/s10620-021-06832.
    >> Share

  54. LI J, Bao S, Wang L, Wang R, et al
    CircZKSCAN1 Suppresses Hepatocellular Carcinoma Tumorigenesis by Regulating miR-873-5p/Downregulation of Deleted in Liver Cancer 1.
    Dig Dis Sci. 2021 Jan 13. pii: 10.1007/s10620-020-06789.
    >> Share

  55. ZHAO L, Ma N, Liu G, Mao N, et al
    Lidocaine Inhibits Hepatocellular Carcinoma Development by Modulating circ_ITCH/miR-421/CPEB3 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06787.
    >> Share

  56. XU R, Yin S, Zheng M, Pei X, et al
    Circular RNA circZFR Promotes Hepatocellular Carcinoma Progression by Regulating miR-375/HMGA2 Axis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06805.
    >> Share

  57. TONTHAT A, Bui D, Romero M, Lo E, et al
    A Case of Benign Hepatic Cyst with Supra-elevated Cyst Fluid Tumor Markers.
    Dig Dis Sci. 2021 Jan 6. pii: 10.1007/s10620-020-06727.
    >> Share

  58. OU H, Liu Q, Lin J, He W, et al
    Pseudogene Annexin A2 Pseudogene 1 Contributes to Hepatocellular Carcinoma Progression by Modulating Its Parental Gene ANXA2 via miRNA-376a-3p.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06734.
    >> Share

  59. MACHADO P, Gupta I, Gummadi S, Stanczak M, et al
    Hepatic Vein Contrast-Enhanced Ultrasound Subharmonic Imaging Signal as a Screening Test for Portal Hypertension.
    Dig Dis Sci. 2021 Jan 4. pii: 10.1007/s10620-020-06790.
    >> Share

  60. BALDIN C, Piedade J, Guimaraes L, Victor L, et al
    CLIF-C AD Score Predicts Development of Acute Decompensations and Survival in Hospitalized Cirrhotic Patients.
    Dig Dis Sci. 2021 Jan 3. pii: 10.1007/s10620-020-06791.
    >> Share

  61. HUANG Y, Chu P, Bao G
    Silencing of Long Non-coding RNA TTN-AS1 Inhibits Hepatocellular Carcinoma Progression by the MicroRNA-134/ITGB1 Axis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06737.
    >> Share

  62. HSU CY, Parikh ND, Huo TI, Tapper EB, et al
    Comparison of Seven Noninvasive Models for Predicting Decompensation and Hospitalization in Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jan 2. pii: 10.1007/s10620-020-06763.
    >> Share

  63. CAVAZZA A, McPhail MJ
    Absolutely FABulous? FABP-1 in Non-acetaminophen-related Acute Liver Failure.
    Dig Dis Sci. 2021;66:10-11.
    >> Share

  64. ABBASS A, Khalid S, Farooq U, Rakov N, et al
    If DILI Is Suspected, Don't Dally.
    Dig Dis Sci. 2021;66:52-55.
    >> Share

  65. PATEL HK, Saxena R, Rush N, Patel SK, et al
    A Comparative Study of 22G versus 19G Needles for EUS-Guided Biopsies for Parenchymal Liver Disease: Are Thinner Needles Better?
    Dig Dis Sci. 2021;66:238-246.
    >> Share

  66. KARVELLAS CJ, Speiser JL, Tremblay M, Lee WM, et al
    Elevated Serum Liver-Type Fatty Acid Binding Protein Levels in Non-acetaminophen Acute Liver Failure Patients with Organ Dysfunction.
    Dig Dis Sci. 2021;66:273-283.
    >> Share

  67. KIM D, Yoo ER, Li AA, Tighe SP, et al
    Trends in Hospitalizations for Clostridioides difficile Infection in End-Stage Liver Disease, 2005-2014.
    Dig Dis Sci. 2021;66:296-307.
    >> Share

    December 2020
  68. BERGQUIST JR, Li AY, Chang EM, Scott GD, et al
    Nearing the Summit: Associating Liver Partitioning and Portal Ligation for Staged Hepatectomy (ALPPS) in Progressive Carcinoid Disease.
    Dig Dis Sci. 2020;65:3482-3485.
    >> Share

  69. LI Q, Rempel JD, Ball TB, Aukema H, et al
    Plasma Oxylipins Levels in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3605-3613.
    >> Share

    November 2020
  70. KLOSTER ML, Ren A, Shah KY, Alqadi MM, et al
    High Incidence of Hepatic Encephalopathy After Viatorr Controlled Expansion Transjugular Intrahepatic Portosystemic Shunt Creation.
    Dig Dis Sci. 2020 Nov 24. pii: 10.1007/s10620-020-06716.
    >> Share

  71. O'LEARY JG, Rajender Reddy K, Tandon P, Biggins SW, et al
    Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax.
    Dig Dis Sci. 2020 Nov 13. pii: 10.1007/s10620-020-06677.
    >> Share

  72. NAYMAGON L, Tremblay D, Zubizarreta N, Moshier E, et al
    Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein Thrombosis.
    Dig Dis Sci. 2020 Nov 5. pii: 10.1007/s10620-020-06695.
    >> Share

  73. BERGQUIST JR, Li AY, Javadi CS, Chima RS, et al
    Too Big to Fail: Successful Resection of a Large Hepatocellular Carcinoma with Portal Tumor Thrombus.
    Dig Dis Sci. 2020 Nov 3. pii: 10.1007/s10620-020-06682.
    >> Share

  74. ABY ES, Pham NV, Yum JJ, Dong TS, et al
    Frailty Does Not Impact Caregiver Burden in Patients with Cirrhosis.
    Dig Dis Sci. 2020 Nov 2. pii: 10.1007/s10620-020-06687.
    >> Share

  75. GREWAL J, Benhammou J, Patel PV, Saab S, et al
    Casting a Wider NET: An Unusual Cause of Acute Liver Failure in a Pregnant Patient.
    Dig Dis Sci. 2020;65:3102-3105.
    >> Share

  76. STINE JG, Xu D, Schmitz K, Sciamanna C, et al
    Exercise Attenuates Ribosomal Protein Six Phosphorylation in Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3238-3243.
    >> Share

  77. SINGH A, Amin H, Garg R, Gupta M, et al
    Increased Prevalence of Obesity and Metabolic Syndrome in Patients with Alcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:3341-3349.
    >> Share

  78. CHEN HW, Ferrando A, White MG, Dennis RA, et al
    Home-Based Physical Activity and Diet Intervention to Improve Physical Function in Advanced Liver Disease: A Randomized Pilot Trial.
    Dig Dis Sci. 2020;65:3350-3359.
    >> Share

  79. ZHANG C, Wu Y, Yuan S, Dou X, et al
    Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types.
    Dig Dis Sci. 2020;65:3360-3368.
    >> Share

    October 2020
  80. WANG B, Zhao K, Hu W, Ding Y, et al
    Protective Mechanism of MIF Inhibitor ISO-1 on Intrahepatic Bile Duct Cells in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2020 Oct 29. pii: 10.1007/s10620-020-06674.
    >> Share

  81. CLARKE K, Bilal M, Sanchez-Luna SA, Dalessio S, et al
    Impact of COVID-19 Pandemic on Training: Global Perceptions of Gastroenterology and Hepatology Fellows in the USA.
    Dig Dis Sci. 2020 Oct 19. pii: 10.1007/s10620-020-06655.
    >> Share

  82. JI C, Hong X, Lan B, Lin Y, et al
    Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
    Dig Dis Sci. 2020 Oct 11. pii: 10.1007/s10620-020-06641.
    >> Share

  83. MUNOZ AE, Pollarsky F, Marino M, Cartier M, et al
    Safety of Chronic Simvastatin Treatment in Patients with Decompensated Cirrhosis: Many Adverse Events but No Liver Injury.
    Dig Dis Sci. 2020 Oct 9. pii: 10.1007/s10620-020-06630.
    >> Share

  84. ATHYROS VG, Katsiki N, Mikhailidis DP
    NAFLD and Statins.
    Dig Dis Sci. 2020;65:3052-3053.
    >> Share

  85. ZHANG Z, Yao W, Yuan D, Huang F, et al
    Effects of Connexin 32-Mediated Lung Inflammation Resolution During Liver Ischemia Reperfusion.
    Dig Dis Sci. 2020;65:2914-2924.
    >> Share

    September 2020
  86. NATARAJAN Y, Tansel A, Patel P, Emelogu IK, et al
    Correction to: Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Sep 29. pii: 10.1007/s10620-020-06619.
    >> Share

  87. CHEN VL, Hawa F, Berinstein JA, Reddy CA, et al
    Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19.
    Dig Dis Sci. 2020 Sep 27. pii: 10.1007/s10620-020-06618.
    >> Share

  88. XIAO F, Gao M, Yang J, He L, et al
    FAM172A Deletion May Enhance Hepatic Steatosis by Promoting ER Stress.
    Dig Dis Sci. 2020 Sep 18. pii: 10.1007/s10620-020-06601.
    >> Share

  89. TRIEU H, Patel A, Wells C, Saab S, et al
    Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Sep 14. pii: 10.1007/s10620-020-06582.
    >> Share

  90. RITACCIO G, Stoleru G, Abutaleb A, Cross RK, et al
    Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare.
    Dig Dis Sci. 2020 Sep 7. pii: 10.1007/s10620-020-06588.
    >> Share

  91. SIMONS-LINARES CR, Abushamma S, Romero-Marrero C, Bhatt A, et al
    Clinical Outcomes of Acute Pancreatitis in Patients with Cirrhosis According to Liver Disease Severity Scores.
    Dig Dis Sci. 2020 Sep 6. pii: 10.1007/s10620-020-06575.
    >> Share

  92. SHAW J, Patidar KR, Reuter B, Hajezifar N, et al
    Focused Education Increases Hepatocellular Cancer Screening in Patients with Cirrhosis Regardless of Functional Health Literacy.
    Dig Dis Sci. 2020 Sep 5. pii: 10.1007/s10620-020-06583.
    >> Share

  93. PATEL A, Asch S, Antonio AL, Kanwal F, et al
    Measuring the Quality of Palliative Care for Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2020;65:2562-2570.
    >> Share

  94. SHALIMAR, Sharma S, Gamanagatti SR, Chauhan A, et al
    Acute-on-Chronic Liver Failure in Budd-Chiari Syndrome: Profile and Predictors of Outcome.
    Dig Dis Sci. 2020;65:2719-2729.
    >> Share

  95. AYYAGARI S, Tan MC, Liu Y, El-Serag HB, et al
    Use of Acid-Suppressant Medications After Diagnosis Increases Mortality in a Subset of Gastrointestinal Cancer Patients.
    Dig Dis Sci. 2020;65:2691-2699.
    >> Share

    August 2020
  96. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    >> Share

  97. HYUN HK, Cho EJ, Park SY, Hong YM, et al
    Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study.
    Dig Dis Sci. 2020 Aug 28. pii: 10.1007/s10620-020-06533.
    >> Share

  98. PHAW NA, Dyson JK, Mells G, Jones D, et al
    Understanding Fatigue in Primary Biliary Cholangitis.
    Dig Dis Sci. 2020 Aug 26. pii: 10.1007/s10620-020-06502.
    >> Share

  99. REICHERT MC, Massmann A, Schulz A, Buecker A, et al
    Volume-Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE-A Feasibility Study.
    Dig Dis Sci. 2020 Aug 20. pii: 10.1007/s10620-020-06535.
    >> Share

  100. PALERMO A, Gerussi A, Mulinacci G, Invernizzi P, et al
    Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All.
    Dig Dis Sci. 2020 Aug 13. pii: 10.1007/s10620-020-06528.
    >> Share

  101. BALAKRISHNAN M, Seth A, Cortes-Santiago N, Jain S, et al
    External Validation of Four Point-of-Care Noninvasive Scores for Predicting Advanced Hepatic Fibrosis in a Predominantly Hispanic NAFLD Population.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06501.
    >> Share

  102. GRUTTADAURIA S, Pagano D, di Francesco F, Foglio A, et al
    Adult to Adult Living Donor Liver Transplantation in Recipients with Low MELD: A Strategy Intended to Overcome Donor Shortage.
    Dig Dis Sci. 2020 Aug 5. pii: 10.1007/s10620-020-06522.
    >> Share

  103. NATARAJAN Y, Tansel A, Patel P, Emologu K, et al
    Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2020 Aug 2. pii: 10.1007/s10620-020-06498.
    >> Share

  104. PALETI S, Li Y, Okwara C, McCarthy D, et al
    Liver Abscess: A Wolf in Sheep's Clothing.
    Dig Dis Sci. 2020;65:2221-2224.
    >> Share

    July 2020
  105. BLOOM PP, Pasricha TS, Andersson KL, Pratt DS, et al
    Hepatology Consultants Often Disagree on Etiology of Abnormal Liver Biochemistries in COVID-19 but Agree on Management.
    Dig Dis Sci. 2020 Jul 29. pii: 10.1007/s10620-020-06495.
    >> Share

  106. CAO Y, Tao Q, Kao X, Zhu X, et al
    Hsa-circRNA-103809 Promotes Hepatocellular Carcinoma Development via MicroRNA-1270/PLAG1 Like Zinc Finger 2 Axis.
    Dig Dis Sci. 2020 Jul 18. pii: 10.1007/s10620-020-06416.
    >> Share

  107. JIANG L, Chu H, Gao B, Lang S, et al
    Transcriptomic Profiling Identifies Novel Hepatic and Intestinal Genes Following Chronic Plus Binge Ethanol Feeding in Mice.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06461.
    >> Share

  108. LE L, Kullar R, Saleh HM, Saab S, et al
    Preferred Noninvasive Testing for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2020 Jul 15. pii: 10.1007/s10620-020-06382.
    >> Share

  109. XIE X, Dou CY, Zhou Y, Zhou Q, et al
    MicroRNA-503 Targets Mothers Against Decapentaplegic Homolog 7 Enhancing Hepatic Stellate Cell Activation and Hepatic Fibrosis.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06460.
    >> Share

  110. KOTWAL V, Mbachi C, Wang Y, Attar B, et al
    A Novel Score to Predict Esophageal Varices in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 9. pii: 10.1007/s10620-020-06456.
    >> Share

  111. AMJAD W, Alukal J, Zhang T, Maheshwari A, et al
    Two-Dose Hepatitis B Vaccine (Heplisav-B) Results in Better Seroconversion Than Three-Dose Vaccine (Engerix-B) in Chronic Liver Disease.
    Dig Dis Sci. 2020 Jul 2. pii: 10.1007/s10620-020-06437.
    >> Share

  112. MALLEPALLY N, Bilal M, Hernandez-Barco YG, Simons M, et al
    The New Virtual Reality: How COVID-19 Will Affect the Gastroenterology and Hepatology Fellowship Match.
    Dig Dis Sci. 2020 Jul 1. pii: 10.1007/s10620-020-06432.
    >> Share

  113. MORNINGSTAR JE, Syn WK, Litwin SE
    The Emerging Epidemic of Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: True, True, and Related?
    Dig Dis Sci. 2020;65:1885-1887.
    >> Share

  114. SHRESTHA MP, Senussi N, Volpicelli N, McCarthy D, et al
    Tangled Up in Red Cells: A Large Liver Mass with Intravascular Hemolysis.
    Dig Dis Sci. 2020;65:1960-1963.
    >> Share

  115. LABENZ C, Huber Y, Michel M, Nagel M, et al
    Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
    Dig Dis Sci. 2020;65:2112-2119.
    >> Share

    June 2020
  116. YUE W, Liu Y, Jiang W, Huang J, et al
    Prealbumin and D-dimer as Prognostic Indicators for Rebleeding in Patients with Nonvariceal Upper Gastrointestinal Bleeding.
    Dig Dis Sci. 2020 Jun 24. pii: 10.1007/s10620-020-06420.
    >> Share

  117. LOUISSAINT J, Foster C, Harding-Theobald E, Lok AS, et al
    Social Support Does Not Modify the Risk of Readmission for Patients with Decompensated Cirrhosis.
    Dig Dis Sci. 2020 Jun 23. pii: 10.1007/s10620-020-06421.
    >> Share

  118. GOTO T, Selzner M
    Low-Pressure Tactic: A Novel Intrahepatic Shunt Improves Outcomes in Experimental Small-for-Size Syndrome.
    Dig Dis Sci. 2020 Jun 18. pii: 10.1007/s10620-020-06385.
    >> Share

  119. KEGASAWA T, Sakamori R, Maesaka K, Yamada R, et al
    Lower Serum Sodium Levels Are Associated with the Therapeutic Effect of Sorafenib on Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Jun 17. pii: 10.1007/s10620-020-06380.
    >> Share

  120. HO SY, Hsu CY, Liu PH, Lee RC, et al
    Albumin-Bilirubin (ALBI) Grade-Based Nomogram for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
    Dig Dis Sci. 2020 Jun 16. pii: 10.1007/s10620-020-06384.
    >> Share

  121. DANFORD CJ, Lee JY, Strohbehn IA, Corey KE, et al
    Development of an Algorithm to Identify Cases of Nonalcoholic Steatohepatitis Cirrhosis in the Electronic Health Record.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06388.
    >> Share

  122. LONG MD, Raffals L, Williams R
    Program Directors' Perspectives of Gastroenterology and Hepatology Fellowship Application.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06378.
    >> Share

  123. ADEJUMO AC, Akhtar DH, Dennis BB, Cholankeril G, et al
    Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA.
    Dig Dis Sci. 2020 Jun 13. pii: 10.1007/s10620-020-06402.
    >> Share

  124. BARAKAT MT, Josephs S, Gugig R
    Return to Native Drainage: Duodenal Biliary Fistula Formation Following Pediatric Hepatobiliary Surgery with Roux-en-Y Reconstruction.
    Dig Dis Sci. 2020 Jun 12. pii: 10.1007/s10620-020-06372.
    >> Share

  125. SHIN JW, Jeong J, Jung SW, Lee SB, et al
    Comparable Incidence of Hepatocellular Carcinoma in Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir.
    Dig Dis Sci. 2020 Jun 10. pii: 10.1007/s10620-020-06375.
    >> Share

  126. TERBAH R, Gow P, Sinclair M, Testro A, et al
    Terlipressin for Type 1 Hepatorenal Syndrome.
    Dig Dis Sci. 2020 Jun 8. pii: 10.1007/s10620-020-06370.
    >> Share

  127. WANG CW, Lebsack A, Sudore RL, Lai JC, et al
    Low Rates of Advance Care Planning (ACP) Discussions Despite Readiness to Engage in ACP Among Liver Transplant Candidates.
    Dig Dis Sci. 2020 Jun 4. pii: 10.1007/s10620-020-06369.
    >> Share

  128. LONARDO A, Targher G
    Cardiovascular Risk in NAFLD: An Intimate Relationship?
    Dig Dis Sci. 2020;65:1593-1595.
    >> Share

  129. SHAO C, Ye J, Li F, Lin Y, et al
    Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients.
    Dig Dis Sci. 2020;65:1850-1860.
    >> Share

    May 2020
  130. KHOKHAR MA, O'Beirne J
    Transjugular Intrahepatic Portosystemic Shunts for Hepatorenal Syndrome: TIPping the Scales in Whose Favor?
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06351.
    >> Share

  131. SHROFF H, Rinella ME
    Thanks to CLD for Small Favors: Reduced CVD Risk in Patients Awaiting Liver Transplantation.
    Dig Dis Sci. 2020 May 29. pii: 10.1007/s10620-020-06322.
    >> Share

  132. LUI FH, Ma P, Helmy M, Hu KQ, et al
    Ultrasonographic (US) Two-Dimensional Measurement of Spleen Is Superior to Traditional Length Measurement Alone in Diagnosing Cirrhosis.
    Dig Dis Sci. 2020 May 23. pii: 10.1007/s10620-020-06332.
    >> Share

  133. CHAHAL D, Yoshida EM, Arbour L, Wallach JP, et al
    Post-partum Primary Biliary Cholangitis Preceded by Intrahepatic Cholestasis of Pregnancy in Three First Nation Patients.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06333.
    >> Share

  134. NAGAOKA K, Ogawa K, Ji C, Cao KY, et al
    Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
    Dig Dis Sci. 2020 May 22. pii: 10.1007/s10620-020-06330.
    >> Share

  135. FERRARESE A, Burra P, Senzolo M
    A Commentary on the Interplay Between Severity of Liver Disease and Bacterial Infection in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2020 May 8. pii: 10.1007/s10620-020-06278.
    >> Share

  136. FAHAD H, Sarmini MT, Modaresi-Esfeh J
    Does Obesity Affect Outcomes of Transjugular Intrahepatic Portosystemic Shunt Placement?
    Dig Dis Sci. 2020 May 6. pii: 10.1007/s10620-020-06276.
    >> Share

  137. CHEN X, Liu C, Ruan L
    G-Protein-Coupled Receptors 120 Agonist III Improves Hepatic Inflammation and ER Stress in Steatohepatitis.
    Dig Dis Sci. 2020 May 5. pii: 10.1007/s10620-020-06280.
    >> Share

  138. IZZY M, Shingina A
    Functional Status and Liver Disease Phenotype: Frailty, Thy Presence Is Ominous.
    Dig Dis Sci. 2020;65:1296-1298.
    >> Share

  139. MUKTHINUTHALAPATI VVPK, Attar BM, Parra-Rodriguez L, Cabrera NL, et al
    Risk Factors, Management, and Outcomes of Pyogenic Liver Abscess in a US Safety Net Hospital.
    Dig Dis Sci. 2020;65:1529-1538.
    >> Share

    April 2020
  140. ZHANG G, Ma J, Xiong J, Huang X, et al
    Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 29. pii: 10.1007/s10620-020-06277.
    >> Share

  141. LIU GM, Zeng HD, Zhang CY, Xu JW, et al
    Identification of METTL3 as an Adverse Prognostic Biomarker in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 24. pii: 10.1007/s10620-020-06260.
    >> Share

  142. ACHARYA C, White MB, Fagan A, Sterling RK, et al
    Liver Transplant Is Associated with Sustained Improvement in Tandem Gait and Risk of Falls.
    Dig Dis Sci. 2020 Apr 22. pii: 10.1007/s10620-020-06261.
    >> Share

  143. EL-SERAG HB, Sardell R, Thrift AP, Kanwal F, et al
    Texas Has the Highest Hepatocellular Carcinoma Incidence Rates in the USA.
    Dig Dis Sci. 2020 Apr 17. pii: 10.1007/s10620-020-06231.
    >> Share

  144. BLOOM PP
    A Call to Action: Novel Ways that Hepatologists Can Contribute to Patient Care During the COVID-19 Pandemic.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06251.
    >> Share

  145. TESTINO G
    Transjugular Intrahepatic Porto Systemic Shunt for Hepatorenal Syndrome in Alcoholic Patients.
    Dig Dis Sci. 2020 Apr 13. pii: 10.1007/s10620-020-06243.
    >> Share

  146. MOCTEZUMA-VELAZQUEZ C, Montano-Loza AJ, Meza-Junco J, Burak K, et al
    Selective Internal Radiation Therapy for Hepatocellular Carcinoma Across the Barcelona Clinic Liver Cancer Stages.
    Dig Dis Sci. 2020 Apr 12. pii: 10.1007/s10620-020-06245.
    >> Share

  147. SUN RF, Zhao CY, Chen S, Yu W, et al
    Androgen Receptor Stimulates Hexokinase 2 and Induces Glycolysis by PKA/CREB Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2020 Apr 9. pii: 10.1007/s10620-020-06229.
    >> Share

  148. TURKSEVEN S, Bolognesi M, Di Pascoli M
    Contribution of Splenic Resistance Arteries to Splanchnic Blood Overflow in Cirrhosis.
    Dig Dis Sci. 2020 Apr 2. pii: 10.1007/s10620-020-06233.
    >> Share

  149. TIEN PC, Duarte M, Roque A, Price J, et al
    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?
    Dig Dis Sci. 2020;65:928-930.
    >> Share

  150. SHERIF ZA
    Unmasking a Stealth Killer: The Need for Increased Awareness of NASH.
    Dig Dis Sci. 2020;65:987-989.
    >> Share

  151. KAPLAN DE
    A Matter of TACEte: Plain Vanilla or Combination?
    Dig Dis Sci. 2020;65:934-936.
    >> Share

  152. DIPAOLA F, Trout AT, Walther AE, Gupta A, et al
    Congenital Portosystemic Shunts in Children: Associations, Complications, and Outcomes.
    Dig Dis Sci. 2020;65:1239-1251.
    >> Share

  153. SINGH A, Dhaliwal AS, Singh S, Kumar A, et al
    Awareness of Nonalcoholic Fatty Liver Disease Is Increasing but Remains Very Low in a Representative US Cohort.
    Dig Dis Sci. 2020;65:978-986.
    >> Share

    March 2020
  154. ZORI A, Villanueva F, Hatamleh D, Ismael M, et al
    Favorable Survival with Non-curative Treatments for Patients with Early-Stage Hepatocellular Carcinoma After Liver Transplant Denial.
    Dig Dis Sci. 2020 Mar 26. pii: 10.1007/s10620-020-06201.
    >> Share

  155. WANG C, Luo J, Chen Z, Ye M, et al
    MiR-375 Impairs the Invasive Capabilities of Hepatoma Cells by Targeting HIF1alpha Under Hypoxia.
    Dig Dis Sci. 2020 Mar 25. pii: 10.1007/s10620-020-06202.
    >> Share

  156. PATEL S, Siddiqui MB, Chandrakumaran A, Rodriguez VA, et al
    Progression to Cirrhosis Leads to Improvement in Atherogenic Milieu.
    Dig Dis Sci. 2020 Mar 18. pii: 10.1007/s10620-020-06196.
    >> Share

  157. O'LEARY JG, Tandon P, Reddy KR, Biggins SW, et al
    Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06168.
    >> Share

  158. LI J, Dong S, Ye M, Peng G, et al
    MicroRNA-489-3p Represses Hepatic Stellate Cells Activation by Negatively Regulating the JAG1/Notch3 Signaling Pathway.
    Dig Dis Sci. 2020 Mar 7. pii: 10.1007/s10620-020-06174.
    >> Share

  159. ZHANG L, Tai Y, Tang S, Zhao C, et al
    Compromised Ileal Mucus Barrier Due to Impaired Epithelial Homeostasis Caused by Notch1 Signaling in Cirrhotic Rats.
    Dig Dis Sci. 2020 Mar 6. pii: 10.1007/s10620-020-06178.
    >> Share

  160. SHAMA S, Liu W
    Omega-3 Fatty Acids and Gut Microbiota: A Reciprocal Interaction in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2020;65:906-910.
    >> Share

  161. LECHNER S, Yee M, Limketkai BN, Pham EA, et al
    Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
    Dig Dis Sci. 2020;65:897-905.
    >> Share

    February 2020
  162. FRICKER ZP, Mukthinuthalapati VVPK, Akinyeye S, Chalasani N, et al
    MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis.
    Dig Dis Sci. 2020 Feb 25. pii: 10.1007/s10620-020-06164.
    >> Share

  163. CHARILAOU P, Devani K, Petrosyan R, Reddy C, et al
    Inpatient Mortality Benefit with Transjugular Intrahepatic Portosystemic Shunt for Hospitalized Hepatorenal Syndrome Patients.
    Dig Dis Sci. 2020 Feb 15. pii: 10.1007/s10620-020-06136.
    >> Share

  164. NEUBERGER J
    Liver Transplantation for Alcoholic Liver Disease: What Is the Risk and Consequence of Relapse?
    Dig Dis Sci. 2020 Feb 14. pii: 10.1007/s10620-020-06127.
    >> Share

  165. SINN DH, Lee HW, Paik YH, Kim DY, et al
    Patterns and Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Invasion: A Multicenter Prospective Cohort Study.
    Dig Dis Sci. 2020 Feb 13. pii: 10.1007/s10620-020-06134.
    >> Share

  166. RAMAI D, Ofosu A, Lai JK, Gao ZH, et al
    Fibrolamellar Hepatocellular Carcinoma: A Population-Based Observational Study.
    Dig Dis Sci. 2020 Feb 12. pii: 10.1007/s10620-020-06135.
    >> Share

    January 2020
  167. LEE EW, Lee AE, Saab S, Kee ST, et al
    Retrograde Transvenous Obliteration (RTO): A New Treatment Option for Hepatic Encephalopathy.
    Dig Dis Sci. 2020 Jan 31. pii: 10.1007/s10620-020-06050.
    >> Share

  168. MURPHY SL, Richardson JK, Blackwood J, Martinez B, et al
    Neurocognitive and Muscular Capacities Are Associated with Frailty in Adults with Cirrhosis.
    Dig Dis Sci. 2020 Jan 25. pii: 10.1007/s10620-020-06099.
    >> Share

  169. CHIANG RS, Parish A, Niedzwiecki D, Kappus MR, et al
    Impact of Malnutrition on Outcomes in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Insertion.
    Dig Dis Sci. 2020 Jan 21. pii: 10.1007/s10620-019-06038.
    >> Share

  170. SASSO R, Lauzon S, Rockey DC
    Cirrhotic Patients on Mechanical Ventilation Have a Low Rate of Successful Extubation and Survival.
    Dig Dis Sci. 2020 Jan 20. pii: 10.1007/s10620-020-06051.
    >> Share

  171. HO SY, Yuan MH, Chen CC, Liu PH, et al
    Differential Survival Impact of Diabetes Mellitus on Hepatocellular Carcinoma: Role of Staging Determinants.
    Dig Dis Sci. 2020 Jan 18. pii: 10.1007/s10620-020-06053.
    >> Share

  172. PERRY LM, Loehfelm T, Pillai R, Pan DY, et al
    Shifting the Treatment Paradigm for Pancreaticoportal Fistula Causing Hepatic Necrosis.
    Dig Dis Sci. 2020 Jan 9. pii: 10.1007/s10620-020-06045.
    >> Share

  173. GUEDES RR, Kieling CO, Dos Santos JL, da Rocha C, et al
    Severity of Ascites Is Associated with Increased Mortality in Patients with Cirrhosis Secondary to Biliary Atresia.
    Dig Dis Sci. 2020 Jan 6. pii: 10.1007/s10620-019-06029.
    >> Share

  174. ZHAO XM, Zhang J, Liang YN, Niu YC, et al
    Astragaloside IV Synergizes with Ferulic Acid to Alleviate Hepatic Fibrosis in Bile Duct-Ligated Cirrhotic Rats.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06017.
    >> Share

  175. ALLEGRITTI M, Enrico B, Basile E, de Vito L, et al
    Non-cirrhotic Extra-Hepatic Porto-Systemic Shunt Causing Adult-Onset Encephalopathy Treated with Endovascular Closure.
    Dig Dis Sci. 2020 Jan 3. pii: 10.1007/s10620-019-06024.
    >> Share

  176. POLANCO NAP, McNally BB, Levy C, Carey EJ, et al
    Gender Differences in Hepatology Medical Literature.
    Dig Dis Sci. 2020 Jan 2. pii: 10.1007/s10620-019-06025.
    >> Share

  177. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    >> Share

  178. LU J, Wang H, Zhang R, Wan Z, et al
    Effects of Photoperiod on Acetaminophen-Induced Hepatotoxicity in Mice.
    Dig Dis Sci. 2020;65:178-188.
    >> Share

  179. MILES DA, Levi CS, Uhanova J, Cuvelier S, et al
    Pocket-Sized Versus Conventional Ultrasound for Detecting Fatty Infiltration of the Liver.
    Dig Dis Sci. 2020;65:82-85.
    >> Share

    December 2019
  180. UNGER LW, Forstner B, Muckenhuber M, Scheuba K, et al
    Hepatic Steatosis in Lean Patients: Risk Factors and Impact on Mortality.
    Dig Dis Sci. 2019 Dec 24. pii: 10.1007/s10620-019-06000.
    >> Share

  181. CHEN W, Li K, Zhu K, Yan R, et al
    RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Dec 19. pii: 10.1007/s10620-019-06007.
    >> Share

  182. WANG X, Luo X, Zhao M, Song J, et al
    Prognostic Factors for Acute Transjugular Intrahepatic Portosystemic Shunt Occlusion Using Expanded Polytetrafluoroethylene-Covered Stent.
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06008.
    >> Share

  183. KAPS L, Grambihler A, Yemane B, Nagel M, et al
    Symptom Burden and Treatment Response in Patients with Primary Biliary Cholangitis (PBC).
    Dig Dis Sci. 2019 Dec 18. pii: 10.1007/s10620-019-06009.
    >> Share

  184. MAHFOUZ M, Nguyen H, Tu J, Diaz CR, et al
    Knowledge and Perceptions of Hepatitis B and Hepatocellular Carcinoma Screening Guidelines Among Trainees: A Tale of Three Centers.
    Dig Dis Sci. 2019 Dec 7. pii: 10.1007/s10620-019-05980.
    >> Share

  185. YANG Y, Liu C, Qi L, Zhao T, et al
    Diagnosis of Pre-HCC Disease by Hepatobiliary-Specific Contrast-Enhanced Magnetic Resonance Imaging: A Review.
    Dig Dis Sci. 2019 Dec 5. pii: 10.1007/s10620-019-05981.
    >> Share

    November 2019
  186. CANNON MD, Martin P, Carrion AF
    Bacterial Infection in Patients with Cirrhosis: Don't Get Bugged to Death.
    Dig Dis Sci. 2019 Nov 25. pii: 10.1007/s10620-019-05943.
    >> Share

  187. OU HY, Cheng YF, Chuang YH, Hsu HW, et al
    Quantification of Functional MR Predicts Early Response in Post-doxorubicin Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Nov 15. pii: 10.1007/s10620-019-05951.
    >> Share

  188. HSU PY, Hsu CT, Yeh ML, Huang CF, et al
    Early Fibrosis but Late Tumor Stage and Worse Outcomes in Hepatocellular Carcinoma Patients Without Hepatitis B or Hepatitis C.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05938.
    >> Share

  189. GU C, Chai M, Liu J, Wang H, et al
    Expansion of Transdifferentiated Human Hepatocytes in a Serum-Free Microcarrier Culture System.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05925.
    >> Share

  190. GOUDRA B, Singh PM
    GI Endoscopy Sedation in Patients with Cirrhosis: Routine or Unpredictable?
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05949.
    >> Share

  191. VUYYURU SK, Singh AD, Gamanagatti SR, Rout G, et al
    A Randomized Control Trial of Thromboelastography-Guided Transfusion in Cirrhosis for High-Risk Invasive Liver-Related Procedures.
    Dig Dis Sci. 2019 Nov 13. pii: 10.1007/s10620-019-05939.
    >> Share

  192. ZONG G, Xu Z, Zhang S, Shen Y, et al
    Retraction Note: CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2019 Nov 11. pii: 10.1007/s10620-019-05932.
    >> Share

  193. DEUTSCH-LINK S, Weinrieb RM, Jones LS, Solga SF, et al
    Prior Relapse, Ongoing Alcohol Consumption, and Failure to Engage in Treatment Predict Alcohol Relapse After Liver Transplantation.
    Dig Dis Sci. 2019 Nov 9. pii: 10.1007/s10620-019-05937.
    >> Share

  194. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    >> Share

  195. SIMMONS OL, Meinzer C, Rule J, Lee WM, et al
    Liver Transplantation for Acetaminophen-Induced Acute Liver Failure: Role of Psychiatric Comorbidity in Listing Decisions and Outcomes.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05901.
    >> Share

    October 2019
  196. BIAN X, He X, Yang L, Wu W, et al
    Prognosis of Hepatocellular Carcinoma Among Cancer Survivors with Other Types of Primary Tumors.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05917.
    >> Share

  197. LING C, Khalid S, Martin D, Hanson J, et al
    HCCs and HCAs in Non-cirrhotic Patients: What You See May Not Be Enough.
    Dig Dis Sci. 2019 Oct 30. pii: 10.1007/s10620-019-05920.
    >> Share

  198. HO SY, Liu PH, Hsu CY, Hsia CY, et al
    A New Prognostic Model Based on Albumin-Bilirubin Grade for Hepatocellular Carcinoma Beyond the Milan Criteria.
    Dig Dis Sci. 2019 Oct 28. pii: 10.1007/s10620-019-05813.
    >> Share

  199. SCAGLIONE S, Adams W, Caines A, Devlin P, et al
    Association Between Race/Ethnicity and Insurance Status with Outcomes in Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Oct 23. pii: 10.1007/s10620-019-05890.
    >> Share

  200. MCCABE P, Galoosian A, Wong RJ
    Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    Dig Dis Sci. 2019 Oct 22. pii: 10.1007/s10620-019-05891.
    >> Share

  201. STINE JG, Intagliata NM, Shah NL, Lisman T, et al
    Clinical Cirrhosis Dilemmas: Survey of Practice from the 7th International Coagulation in Liver Disease Conference.
    Dig Dis Sci. 2019 Oct 18. pii: 10.1007/s10620-019-05884.
    >> Share

  202. WANG JH, Ou HY, Yen YH, Chen CH, et al
    Usefulness of Controlled Attenuation Parameter in Detecting and Monitoring Hepatic Steatosis with MRI-PDFF as Reference.
    Dig Dis Sci. 2019 Oct 15. pii: 10.1007/s10620-019-05883.
    >> Share

  203. EDELSON J, Suarez AL, Zhang J, Rockey DC, et al
    Sedation During Endoscopy in Patients with Cirrhosis: Safety and Predictors of Adverse Events.
    Dig Dis Sci. 2019 Oct 12. pii: 10.1007/s10620-019-05845.
    >> Share

  204. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    >> Share

  205. WEN X, Ling S, Wu W, Shan Q, et al
    Ubiquitin-Specific Protease 22/Silent Information Regulator 1 Axis Plays a Pivotal Role in the Prognosis and 5-Fluorouracil Resistance in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Oct 5. pii: 10.1007/s10620-019-05844.
    >> Share

    September 2019
  206. THOMSON MJ, Taylor A, Sharma P, Lok AS, et al
    Limited Progress in Hepatorenal Syndrome (HRS) Reversal and Survival 2002-2018: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2019 Sep 30. pii: 10.1007/s10620-019-05858.
    >> Share

  207. LI Y, Li Z, Jia Y, Ding B, et al
    In Vitro Anti-hepatoma Activities of Notoginsenoside R1 Through Downregulation of Tumor Promoter miR-21.
    Dig Dis Sci. 2019 Sep 26. pii: 10.1007/s10620-019-05856.
    >> Share

  208. KOOLA JD, Ho SB, Cao A, Chen G, et al
    Predicting 30-Day Hospital Readmission Risk in a National Cohort of Patients with Cirrhosis.
    Dig Dis Sci. 2019 Sep 17. pii: 10.1007/s10620-019-05826.
    >> Share

  209. GU S, Chen J, Zhou Q, Yan M, et al
    LRRK2 Is Associated with Recurrence-Free Survival in Intrahepatic Cholangiocarcinoma and Downregulation of LRRK2 Suppresses Tumor Progress In Vitro.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05806.
    >> Share

  210. GALOOSIAN A, Hanlon C, Tana M, Cheung R, et al
    Race/Ethnicity and Insurance-Specific Disparities in In-Hospital Mortality Among Adults with Primary Biliary Cholangitis: Analysis of 2007-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Sep 5. pii: 10.1007/s10620-019-05809.
    >> Share

  211. RAVAIOLI F, Colecchia A
    Sound Conclusions: How Splenic Elastography May Decrease the Need for Endoscopic Variceal Surveillance.
    Dig Dis Sci. 2019;64:2381-2383.
    >> Share

  212. MA J, Qiu Y, Wang M, Zhang M, et al
    Locostatin Alleviates Liver Fibrosis Induced by Carbon Tetrachloride in Mice.
    Dig Dis Sci. 2019;64:2570-2580.
    >> Share

    August 2019
  213. ZHOU Y, Zhang Q, Kong Y, Guo X, et al
    Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05798.
    >> Share

  214. SHERMAN KE, Abdel-Hameed EA, Ehman RL, Rouster SD, et al
    Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
    Dig Dis Sci. 2019 Aug 29. pii: 10.1007/s10620-019-05815.
    >> Share

  215. WALLACE MC, Sek K, Francis RJ, Samuelson S, et al
    Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05781.
    >> Share

  216. FEUERSTADT P, Hong SJ, Brandt LJ
    Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.
    Dig Dis Sci. 2019 Aug 22. pii: 10.1007/s10620-019-05804.
    >> Share

  217. DONG Z, Liao B, Shen W, Sui C, et al
    Expression of Programmed Death Ligand 1 Is Associated with the Prognosis of Intrahepatic Cholangiocarcinoma.
    Dig Dis Sci. 2019 Aug 13. pii: 10.1007/s10620-019-05787.
    >> Share

  218. HAO YL, Bian ZL, Ju LL, Liu Y, et al
    RANK/RANKL Acts as a Protective Factor by Targeting Cholangiocytes in Primary Biliary Cholangitis.
    Dig Dis Sci. 2019 Aug 3. pii: 10.1007/s10620-019-05758.
    >> Share

  219. PHAW NA, Jones DEJ
    PBC: Better Solutions to Beat Feeling Beat.
    Dig Dis Sci. 2019;64:2075-2077.
    >> Share

    July 2019
  220. COSTENTIN CE, Sogni P, Falissard B, Barbare JC, et al
    Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
    Dig Dis Sci. 2019 Jul 25. pii: 10.1007/s10620-019-05724.
    >> Share

  221. TAO J, Li J, Chen X, Guo Y, et al
    Endoscopic Variceal Sequential Ligation Does Not Increase Risk of Gastroesophageal Reflux Disease in Cirrhosis Patients.
    Dig Dis Sci. 2019 Jul 22. pii: 10.1007/s10620-019-05740.
    >> Share

  222. SONG Q, Ren W, Fan L, Zhao M, et al
    Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Dig Dis Sci. 2019 Jul 17. pii: 10.1007/s10620-019-05733.
    >> Share

  223. SAMJI NS, Verma R, Keri KC, Singal AK, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis: Pathophysiology of Recurrence and Clinical Challenges.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05716.
    >> Share

  224. KUZNIETSOVA HM, Dziubenko NV, Lynchak OV, Herheliuk TS, et al
    Effects of Pristine C60 Fullerenes on Liver and Pancreas in alpha-Naphthylisothiocyanate-Induced Cholangitis.
    Dig Dis Sci. 2019 Jul 16. pii: 10.1007/s10620-019-05730.
    >> Share

  225. TUCKER RD, Ciofoaia V, Nadella S, Gay MD, et al
    A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Jul 11. pii: 10.1007/s10620-019-05722.
    >> Share

  226. TAPPER EB, Derstine B, Baki J, Su GL, et al
    Bedside Measures of Frailty and Cognitive Function Correlate with Sarcopenia in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jul 10. pii: 10.1007/s10620-019-05713.
    >> Share

  227. HAGSTROM H, Hemmingsson T, Discacciati A, Andreasson A, et al
    Risk Behaviors Associated with Alcohol Consumption Predict Future Severe Liver Disease.
    Dig Dis Sci. 2019;64:2014-2023.
    >> Share

    June 2019
  228. SEMMLER G, Stift J, Scheiner B, Woran K, et al
    Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
    Dig Dis Sci. 2019 Jun 17. pii: 10.1007/s10620-019-05702.
    >> Share

  229. SOMMARIVA C, Lauro A, Pagano N, Vaccari S, et al
    Subcapsular Hepatic Hematoma Post-ERCP: Case Report and Review of the Literature.
    Dig Dis Sci. 2019 Jun 13. pii: 10.1007/s10620-019-05679.
    >> Share

  230. KIM DS, Lim TS, Jeon MY, Kim BK, et al
    Transarterial Chemoembolization in Treatment-Naive and Recurrent Hepatocellular Carcinoma: A Propensity-Matched Outcome Analysis.
    Dig Dis Sci. 2019 Jun 11. pii: 10.1007/s10620-019-05701.
    >> Share

  231. MANKA P, Bechmann L, Best J, Sydor S, et al
    Low Free Triiodothyronine Is Associated with Advanced Fibrosis in Patients at High Risk for Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2019 Jun 3. pii: 10.1007/s10620-019-05687.
    >> Share

  232. CROPLEY A, Ashrafy AH, Weltman M
    An Original Description of Granulomatous Liver Cirrhosis in Blau Syndrome.
    Dig Dis Sci. 2019 Jun 1. pii: 10.1007/s10620-019-05682.
    >> Share

  233. JENSEN CW, Worhunsky DJ, Triadafilopoulos G, Bingham DB, et al
    Ruptured Oncocytic Intraductal Papillary Neoplasm: Think Beyond the Pancreas.
    Dig Dis Sci. 2019;64:1436-1438.
    >> Share

  234. LIU J, Li H, Sun L, Shen S, et al
    Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Dig Dis Sci. 2019;64:1523-1534.
    >> Share

    May 2019
  235. TU W, Gong J, Tian D, Wang Z, et al
    Hepatitis B Virus X Protein Induces SATB1 Expression Through Activation of ERK and p38MAPK Pathways to Suppress Anoikis.
    Dig Dis Sci. 2019 May 30. pii: 10.1007/s10620-019-05681.
    >> Share

  236. CORBI LE, Tannuri ACA, de Aro Braz MJ, Paes VR, et al
    Does Biliodigestive Anastomosis Have Any Effect on the Reversal of Hepatopulmonary Syndrome in a Biliary Cirrhosis Experimental Model?
    Dig Dis Sci. 2019 May 10. pii: 10.1007/s10620-019-05658.
    >> Share

  237. SIRAMOLPIWAT S, Punjachaipornpon T, Pornthisarn B, Vilaichone RK, et al
    N-Acetylcysteine Prevents Post-embolization Syndrome in Patients with Hepatocellular Carcinoma Following Transarterial Chemoembolization.
    Dig Dis Sci. 2019 May 9. pii: 10.1007/s10620-019-05652.
    >> Share

  238. ALMANZA D, Gharaee-Kermani M, Zhilin-Roth A, Rodriguez-Nieves JA, et al
    Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature.
    Dig Dis Sci. 2019;64:1257-1269.
    >> Share

    April 2019
  239. LI X, Jiang F, Ge Z, Chen B, et al
    Fructose-Bisphosphate Aldolase A Regulates Hypoxic Adaptation in Hepatocellular Carcinoma and Involved with Tumor Malignancy.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05642.
    >> Share

  240. ZOU WY, Choi K, Kramer JR, Yu X, et al
    Risk of Hepatocellular Cancer Recurrence in Hepatitis C Virus+ Patients Treated with Direct-Acting Antiviral Agents.
    Dig Dis Sci. 2019 Apr 30. pii: 10.1007/s10620-019-05641.
    >> Share

  241. DEMORROW S
    Concise Commentary: Staying True to Type-The Increasing Inpatient Burden of Hepatic Encephalopathy.
    Dig Dis Sci. 2019 Apr 29. pii: 10.1007/s10620-019-05630.
    >> Share

  242. KALANI A, Phan J, Taefi A, Deshmukh M, et al
    Necrotizing Pancreatitis: Common and Uncommon Sequelae and Solutions.
    Dig Dis Sci. 2019 Apr 27. pii: 10.1007/s10620-019-05634.
    >> Share

  243. KARAGIANNAKIS DS, Voulgaris T, Koureta E, Chloupi E, et al
    Role of Spleen Stiffness Measurement by 2D-Shear Wave Elastography in Ruling Out the Presence of High-Risk Varices in Cirrhotic Patients.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05616.
    >> Share

  244. NAKATAKE R, Hishikawa H, Kotsuka M, Ishizaki M, et al
    The Proton Pump Inhibitor Lansoprazole Has Hepatoprotective Effects in In Vitro and In Vivo Rat Models of Acute Liver Injury.
    Dig Dis Sci. 2019 Apr 15. pii: 10.1007/s10620-019-05622.
    >> Share

  245. YU B, Ding Y, Liao X, Wang C, et al
    Overexpression of PARPBP Correlates with Tumor Progression and Poor Prognosis in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Apr 4. pii: 10.1007/s10620-019-05608.
    >> Share

  246. PILLAI A, Couri T, Charlton M
    Liver Allocation Policies in the USA: Past, Present, and the Future.
    Dig Dis Sci. 2019;64:985-992.
    >> Share

  247. GADSDEN MM, Kaplan DE
    Multidisciplinary Approach to HCC Management: How Can This Be Done?
    Dig Dis Sci. 2019;64:968-975.
    >> Share

  248. LANGE N, Dufour JF
    Changing Epidemiology of HCC: How to Screen and Identify Patients at Risk?
    Dig Dis Sci. 2019;64:903-909.
    >> Share

  249. BAILEY CW, Sydnor MK Jr
    Current State of Tumor Ablation Therapies.
    Dig Dis Sci. 2019;64:951-958.
    >> Share

  250. VOGL TJ, Gruber-Rouh T
    HCC: Transarterial Therapies-What the Interventional Radiologist Can Offer.
    Dig Dis Sci. 2019;64:959-967.
    >> Share

  251. SHERMAN M
    Design and Endpoints of Clinical Trials, Current and Future.
    Dig Dis Sci. 2019;64:1050-1057.
    >> Share

  252. FLOUDAS CS, Brar G, Greten TF
    Immunotherapy: Current Status and Future Perspectives.
    Dig Dis Sci. 2019;64:1030-1040.
    >> Share

  253. LONGERICH T, Schirmacher P
    Emerging Role of the Pathologist in Precision Medicine for HCC.
    Dig Dis Sci. 2019;64:928-933.
    >> Share

    March 2019
  254. KOHLI R, Shingina A, New S, Chaturvedi S, et al
    Thromboelastography Parameters Are Associated with Cirrhosis Severity.
    Dig Dis Sci. 2019 Mar 26. pii: 10.1007/s10620-019-05597.
    >> Share

  255. YOON YI, Lee SG
    Living Donor Liver Transplantation for Hepatocellular Carcinoma: An Asian Perspective.
    Dig Dis Sci. 2019 Mar 20. pii: 10.1007/s10620-019-05551.
    >> Share

  256. SAFFO S, Taddei TH
    Systemic Management for Advanced Hepatocellular Carcinoma: A Review of the Molecular Pathways of Carcinogenesis, Current and Emerging Therapies, and Novel Treatment Strategies.
    Dig Dis Sci. 2019 Mar 18. pii: 10.1007/s10620-019-05582.
    >> Share

  257. LUO X, Liu Y, Ma S, Liu L, et al
    WDR34 Activates Wnt/Beta-Catenin Signaling in Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 15. pii: 10.1007/s10620-019-05583.
    >> Share

  258. SONI PD, Palta M
    Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: Current State and Future Opportunities.
    Dig Dis Sci. 2019 Mar 14. pii: 10.1007/s10620-019-05539.
    >> Share

  259. WEI M, Ford J, Li Q, Jeong D, et al
    Correction to: Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05558.
    >> Share

  260. HIRODE G, Vittinghoff E, Wong RJ
    Increasing Burden of Hepatic Encephalopathy Among Hospitalized Adults: An Analysis of the 2010-2014 National Inpatient Sample.
    Dig Dis Sci. 2019 Mar 13. pii: 10.1007/s10620-019-05576.
    >> Share

  261. FUCHS M, Levy MF
    Introduction to the Emmet B. Keeffe, MD, Commemorative Special Issue on Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 12. pii: 10.1007/s10620-019-05574.
    >> Share

  262. SPOSITO C, Cucchetti A, Mazzaferro V
    Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05538.
    >> Share

  263. NORONHA FERREIRA C, Reis D, Cortez-Pinto H, Tato Marinho R, et al
    Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Dig Dis Sci. 2019 Mar 9. pii: 10.1007/s10620-019-05572.
    >> Share

  264. KHAN RS, Newsome PN
    Fat and Fibrosis: Does Empagliflozin Impair the Progression of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus?
    Dig Dis Sci. 2019 Mar 7. pii: 10.1007/s10620-019-05573.
    >> Share

  265. REICHMAN TW, Bhati CS, Battula NR
    Obtaining Optimal Long-Term Outcomes from Liver Transplantation for Hepatocellular Cancer.
    Dig Dis Sci. 2019 Mar 6. pii: 10.1007/s10620-019-05550.
    >> Share

  266. HARDING JJ, Khalil DN, Abou-Alfa GK
    Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05517.
    >> Share

  267. SAYINER M, Golabi P, Younossi ZM
    Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
    Dig Dis Sci. 2019 Mar 5. pii: 10.1007/s10620-019-05537.
    >> Share

  268. ROUT G, Sharma S, Gunjan D, Kedia S, et al
    Development and Validation of a Novel Model for Outcomes in Patients with Cirrhosis and Acute Variceal Bleeding.
    Dig Dis Sci. 2019 Mar 4. pii: 10.1007/s10620-019-05557.
    >> Share

  269. MA L, Ishigami M, Honda T, Yokoyama S, et al
    Antifibrotic Effects of 1,25(OH)2D3 on Nonalcoholic Steatohepatitis in Female Mice.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05560.
    >> Share

  270. RONOT M, Purcell Y, Vilgrain V
    Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.
    Dig Dis Sci. 2019 Mar 2. pii: 10.1007/s10620-019-05547.
    >> Share

  271. DISMUKE-GREER CE, Syn WK
    Coming Complications of Nonalcoholic Fatty Liver Disease: Time to GNASH Your Teeth.
    Dig Dis Sci. 2019;64:606-608.
    >> Share

  272. ZHANG W, Chao S, Chen S, Rao H, et al
    Awareness and Knowledge of Nonalcoholic Fatty Liver Disease Among Office Employees in Beijing, China.
    Dig Dis Sci. 2019;64:708-717.
    >> Share

  273. MANTOVANI A
    Nonalcoholic Fatty Liver Disease and Bone Mineral Density in Children and Adolescents: Specific Considerations for Future Studies.
    Dig Dis Sci. 2019;64:898-900.
    >> Share

  274. KANG HT, Jun DW, Jang K, Hoh JK, et al
    Effect of Stem Cell Treatment on Acute Liver Failure Model Using Scaffold.
    Dig Dis Sci. 2019;64:781-791.
    >> Share

  275. NGUYEN AL, Park H, Nguyen P, Sheen E, et al
    Rising Inpatient Encounters and Economic Burden for Patients with Nonalcoholic Fatty Liver Disease in the USA.
    Dig Dis Sci. 2019;64:698-707.
    >> Share

    February 2019
  276. JIAN ZW, Wu XW, Chen ZX, Wang JC, et al
    Effect of Nucleos(t)ide Analogs on Patients with Intermediate and Advanced Hepatitis B Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2019 Feb 28. pii: 10.1007/s10620-019-05543.
    >> Share

  277. XIAO Y, Zhang S, Li Q, Liu Z, et al
    miR-219a-5p Ameliorates Hepatic Ischemia/Reperfusion Injury via Impairing TP53BP2.
    Dig Dis Sci. 2019 Feb 22. pii: 10.1007/s10620-019-05535.
    >> Share

  278. ARDOLINO E, Wang SS, Patwardhan VR
    Evidence of Significant Ceftriaxone and Quinolone Resistance in Cirrhotics with Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2019 Feb 14. pii: 10.1007/s10620-019-05519.
    >> Share

  279. ZHAO J, Xu H, Li Y, Gong L, et al
    NAFLD Induction Delays Postoperative Liver Regeneration of ALPPS in Rats.
    Dig Dis Sci. 2019;64:456-468.
    >> Share

  280. XI L, Zhu J, Zhang H, Muktiali M, et al
    Epidemiological Trends in Gastrointestinal Cancers in China: An Ecological Study.
    Dig Dis Sci. 2019;64:532-543.
    >> Share

    January 2019
  281. NEVENS F, Bittencourt PL, Coenraad MJ, Ding H, et al
    Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-018-5448.
    >> Share

  282. LAI LL, Vethakkan SR, Nik Mustapha NR, Mahadeva S, et al
    Empagliflozin for the Treatment of Nonalcoholic Steatohepatitis in Patients with Type 2 Diabetes Mellitus.
    Dig Dis Sci. 2019 Jan 25. pii: 10.1007/s10620-019-5477.
    >> Share

  283. BARRITT AS 4TH, Jiang Y, Schmidt M, Hayashi PH, et al
    Charges for Alcoholic Cirrhosis Exceed All Other Etiologies of Cirrhosis Combined: A National and State Inpatient Survey Analysis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5471.
    >> Share

  284. TANSEL A, Kramer J, Feng H, El-Serag HB, et al
    Risk Trajectories for Readmission and Death After Cirrhosis-Related Hospitalization.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5459.
    >> Share

  285. ZHI SC, Chen SZ, Li YY, Li JJ, et al
    Rosiglitazone Inhibits Activation of Hepatic Stellate Cells via Up-Regulating Micro-RNA-124-3p to Alleviate Hepatic Fibrosis.
    Dig Dis Sci. 2019 Jan 23. pii: 10.1007/s10620-019-5462.
    >> Share

  286. THEOCHARIDOU E, Giouleme O, Anastasiadis S, Markopoulou A, et al
    Free Cortisol Is a More Accurate Marker for Adrenal Function and Does Not Correlate with Renal Function in Cirrhosis.
    Dig Dis Sci. 2019 Jan 19. pii: 10.1007/s10620-019-5460.
    >> Share

  287. BERNARDI N, Chedid MF, Grezzana-Filho TJM, Chedid AD, et al
    Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation.
    Dig Dis Sci. 2019 Jan 14. pii: 10.1007/s10620-019-5456.
    >> Share

  288. WANG S, Liang C, Ai H, Yang M, et al
    Hepatic miR-181b-5p Contributes to Glycogen Synthesis Through Targeting EGR1.
    Dig Dis Sci. 2019 Jan 9. pii: 10.1007/s10620-018-5442.
    >> Share

  289. DAKHOUL L, Jones KR, Gawrieh S, Ghabril M, et al
    Older Age and Disease Duration Are Highly Associated with Hepatocellular Carcinoma in Patients with Autoimmune Hepatitis.
    Dig Dis Sci. 2019 Jan 7. pii: 10.1007/s10620-018-5441.
    >> Share

  290. LEE KC, Hsu WF, Hsieh YC, Chan CC, et al
    Dabigatran Reduces Liver Fibrosis in Thioacetamide-Injured Rats.
    Dig Dis Sci. 2019;64:102-112.
    >> Share

  291. JIAO Y, Li Y, Lu Z, Liu Y, et al
    High Trophinin-Associated Protein Expression Is an Independent Predictor of Poor Survival in Liver Cancer.
    Dig Dis Sci. 2019;64:137-143.
    >> Share

  292. JIN X, Zimmers TA, Zhang Z, Koniaris LG, et al
    Resveratrol Improves Recovery and Survival of Diet-Induced Obese Mice Undergoing Extended Major (80%) Hepatectomy.
    Dig Dis Sci. 2019;64:93-101.
    >> Share

  293. ROSENBLATT R, Mehta A, Snell D, Hissong E, et al
    Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
    Dig Dis Sci. 2019;64:262-268.
    >> Share

  294. LI P, Shan K, Liu Y, Zhang Y, et al
    CircScd1 Promotes Fatty Liver Disease via the Janus Kinase 2/Signal Transducer and Activator of Transcription 5 Pathway.
    Dig Dis Sci. 2019;64:113-122.
    >> Share

    December 2018
  295. STINE JG, Northup PG
    Management of Non-tumoral Portal Vein Thrombosis in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5427.
    >> Share

  296. KAKAR S, Dugum M, Cabello R, Humar A, et al
    Incidence of Recurrent NASH-Related Allograft Cirrhosis.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5413.
    >> Share

  297. MAIMONE S, Saffioti F, Filomia R, Alibrandi A, et al
    Predictors of Re-bleeding and Mortality Among Patients with Refractory Variceal Bleeding Undergoing Salvage Transjugular Intrahepatic Portosystemic Shunt (TIPS).
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5412.
    >> Share

  298. HUANG X, Gao Y, Qin J, Lu S, et al
    miR-214 Down-Regulation Promoted Hypoxia/Reoxygenation-Induced Hepatocyte Apoptosis Through TRAF1/ASK1/JNK Pathway.
    Dig Dis Sci. 2018 Dec 17. pii: 10.1007/s10620-018-5405.
    >> Share

  299. PINERO F, Rubinstein F, Marciano S, Fernandez N, et al
    Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5390.
    >> Share

  300. TOLBOL KS, Stierstorfer B, Rippmann JF, Veidal SS, et al
    Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis.
    Dig Dis Sci. 2018 Dec 3. pii: 10.1007/s10620-018-5395.
    >> Share

  301. SHETTY A, Hsu JW, Manka PP, Syn WK, et al
    Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018;63:3187-3206.
    >> Share

    November 2018
  302. MATSUURA Y, Wada H, Eguchi H, Gotoh K, et al
    Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.
    Dig Dis Sci. 2018 Nov 22. pii: 10.1007/s10620-018-5380.
    >> Share

  303. WANG B, Zhao KL, Hu WJ, Zuo T, et al
    Macrophage Migration Inhibitor Promoted the Intrahepatic Bile Duct Injury in Rats with Severe Acute Pancreatitis.
    Dig Dis Sci. 2018 Nov 22. pii: 10.1007/s10620-018-5379.
    >> Share

  304. JARA M, Dziodzio T, Malinowski M, Luttgert K, et al
    Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2018 Nov 7. pii: 10.1007/s10620-018-5360.
    >> Share

  305. DE MARIA C, Ghidotti I, Grillo F, Giannini EG, et al
    Successful DAA Treatment and Global Improvement in a Cirrhotic Patient with Concomitant HCV Infection and Autoimmune Hepatitis.
    Dig Dis Sci. 2018 Nov 1. pii: 10.1007/s10620-018-5356.
    >> Share

    October 2018
  306. MURPHY SL, Tapper EB, Blackwood J, Richardson JK, et al
    Why Do Individuals with Cirrhosis Fall? A Mechanistic Model for Fall Assessment, Treatment, and Research.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5333.
    >> Share

  307. LIEW ZH, Goh GB, Hao Y, Chang PE, et al
    Comparison of Hepatocellular Carcinoma in Patients with Cryptogenic Versus Hepatitis B Etiology: A Study of 1079 Cases Over 3 Decades.
    Dig Dis Sci. 2018 Oct 16. pii: 10.1007/s10620-018-5331.
    >> Share

  308. CHO SY, Kim S, Son MJ, Rou WS, et al
    Clinical Significance of the Thioredoxin System and Thioredoxin-Domain-Containing Protein Family in Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Oct 4. pii: 10.1007/s10620-018-5307.
    >> Share

    September 2018
  309. KORNBERG A, Schernhammer M, Kornberg J, Friess H, et al
    Serological Risk Index Based on Alpha-Fetoprotein and C-Reactive Protein to Indicate Futile Liver Transplantation Among Patients with Advanced Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5296.
    >> Share

  310. YANNY B, Saab S, Durazo F, Latt N, et al
    Eight-Week Hepatitis C Treatment with New Direct Acting Antivirals Has a Better Safety Profile While Being Effective in the Treatment-Naive Geriatric Population Without Liver Cirrhosis and Hepatitis C Virus-RNA < 6 Million IU/mL.
    Dig Dis Sci. 2018 Sep 27. pii: 10.1007/s10620-018-5283.
    >> Share

  311. OU Q, Weng Y, Wang S, Zhao Y, et al
    Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-kappaB Pathway.
    Dig Dis Sci. 2018 Sep 6. pii: 10.1007/s10620-018-5268.
    >> Share

  312. CHASCSA DM, Lai JC, Dunn MA, Montano-Loza AJ, et al
    Patient and Caregiver Attitudes and Practices of Exercise in Candidates Listed for Liver Transplantation.
    Dig Dis Sci. 2018 Sep 3. pii: 10.1007/s10620-018-5271.
    >> Share

  313. CAO LL, Pei XF, Qiao X, Yu J, et al
    SERPINA3 Silencing Inhibits the Migration, Invasion, and Liver Metastasis of Colon Cancer Cells.
    Dig Dis Sci. 2018;63:2309-2319.
    >> Share

  314. PATEL YA, Gifford EJ, Glass LM, Turner MJ, et al
    Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Dig Dis Sci. 2018;63:2259-2266.
    >> Share

    August 2018
  315. KIM HJ, Kang TU, Swan H, Kang MJ, et al
    Incidence and Prognosis of Subsequent Cholangiocarcinoma in Patients with Hepatic Resection for Bile Duct Stones.
    Dig Dis Sci. 2018 Aug 31. pii: 10.1007/s10620-018-5262.
    >> Share

  316. ADDEPALLY NS, George N, Martinez-Macias R, Garcia-Saenz-de-Sicilia M, et al
    Hemoglobin A1c Has Suboptimal Performance to Diagnose and Monitor Diabetes Mellitus in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Aug 29. pii: 10.1007/s10620-018-5265.
    >> Share

  317. ZHANG G, Yu X, Liu P, Huang X, et al
    Efficacy of Nucleoside Analogs for Chronic Hepatitis B Virus-Related Hepatocellular Carcinoma After Curative Treatment: A Meta-Analysis.
    Dig Dis Sci. 2018 Aug 23. pii: 10.1007/s10620-018-5252.
    >> Share

    July 2018
  318. KALIANNAN K
    Compromise of alpha-Defensin Function in Liver Cirrhosis Facilitates the Toxic Relationship Between Gut Permeability and Endotoxemia.
    Dig Dis Sci. 2018 Jul 14. pii: 10.1007/s10620-018-5197.
    >> Share

  319. SORENSEN M, Larsen LP, Villadsen GE, Aagaard NK, et al
    beta-Blockers Improve Presinusoidal Portal Hypertension.
    Dig Dis Sci. 2018 Jul 12. pii: 10.1007/s10620-018-5186.
    >> Share

  320. LING C, Gavin M, Hanson J, McCarthy DM, et al
    Progressive Epigastric Pain with Abnormal Liver Tests in a Patient with Crohn's Disease: Don't DILI Dally.
    Dig Dis Sci. 2018;63:1751-1755.
    >> Share

  321. MANTOVANI A, Grani G
    Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.
    Dig Dis Sci. 2018;63:1970-1976.
    >> Share

    June 2018
  322. ZHANG S, Gong Y, Xiao J, Chai Y, et al
    A COL1A1 Promoter-Controlled Expression of TGF-beta Soluble Receptor Inhibits Hepatic Fibrosis Without Triggering Autoimmune Responses.
    Dig Dis Sci. 2018 Jun 23. pii: 10.1007/s10620-018-5168.
    >> Share

  323. LENHART A, Hussain S, Salgia R
    Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis.
    Dig Dis Sci. 2018 Jun 22. pii: 10.1007/s10620-018-5170.
    >> Share

  324. OU H, Huang Y, Xiang L, Chen Z, et al
    Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Dig Dis Sci. 2018 Jun 21. pii: 10.1007/s10620-018-5124.
    >> Share

  325. TSIAOUSSIS GI, Papaioannou EC, Kourea EP, Assimakopoulos SF, et al
    Expression of alpha-Defensins, CD20+ B-lymphocytes, and Intraepithelial CD3+ T-lymphocytes in the Intestinal Mucosa of Patients with Liver Cirrhosis: Emerging Mediators of Intestinal Barrier Function.
    Dig Dis Sci. 2018 Jun 7. pii: 10.1007/s10620-018-5146.
    >> Share

  326. KOK B, Lester ELW, Lee WM, Hanje AJ, et al
    Acute Liver Failure from Tumor Necrosis Factor-alpha Antagonists: Report of Four Cases and Literature Review.
    Dig Dis Sci. 2018;63:1654-1666.
    >> Share

    May 2018
  327. BAJAJ JS, Ross D
    Concise Commentary: Remaining Outside the Hospital Is a Golden State in Cirrhosis-Lessons from California.
    Dig Dis Sci. 2018 May 30. pii: 10.1007/s10620-018-5134.
    >> Share

  328. WALLACE MC, Knuiman M, Huang Y, Garas G, et al
    The Prognostic Ability of Major Hepatocellular Carcinoma Staging Systems Is Improved by Including a Treatment Variable.
    Dig Dis Sci. 2018 May 28. pii: 10.1007/s10620-018-5132.
    >> Share

  329. JOPSON L, Khanna A, Peterson P, Rudell E, et al
    Are Clinicians Ready for Safe Use of Stratified Therapy in Primary Biliary Cholangitis (PBC)? A Study of Educational Awareness.
    Dig Dis Sci. 2018 May 8. pii: 10.1007/s10620-018-5074.
    >> Share

  330. SHEN J, Liu J, Li C, Wen T, et al
    The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.
    Dig Dis Sci. 2018 May 7. pii: 10.1007/s10620-018-5077.
    >> Share

  331. WANG P, Li Z, Ren S, Li J, et al
    Spleen Regulates Hematopoietic Stem/Progenitor Cell Functions Through Regulation of EGF in Cirrhotic Hypersplenism.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5091.
    >> Share

  332. FACCIORUSSO A, Roy S, Livadas S, Fevrier-Paul A, et al
    Nonselective Beta-Blockers Do Not Affect Survival in Cirrhotic Patients with Ascites.
    Dig Dis Sci. 2018 May 3. pii: 10.1007/s10620-018-5092.
    >> Share

  333. ROTH CG, Marzio DH, Guglielmo FF
    Contributions of Magnetic Resonance Imaging to Gastroenterological Practice: MRIs for GIs.
    Dig Dis Sci. 2018;63:1102-1122.
    >> Share

  334. KAUNITZ JD
    Magnetic Resonance Imaging: The Nuclear Option.
    Dig Dis Sci. 2018;63:1100-1101.
    >> Share

  335. NIU B, Kim B, Limketkai BN, Sun J, et al
    Mortality from Spontaneous Bacterial Peritonitis Among Hospitalized Patients in the USA.
    Dig Dis Sci. 2018;63:1327-1333.
    >> Share

    April 2018
  336. GARCIA-RODRIGUEZ MT, Pertega-Diaz S, Lopez-Calvino B, Pinon-Villar MDC, et al
    Nomogram and Validity of a Model for Predicting Malnutrition in Patients on Liver Transplant Lists.
    Dig Dis Sci. 2018 Apr 25. pii: 10.1007/s10620-018-5079.
    >> Share

  337. ILAN Y
    Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?
    Dig Dis Sci. 2018 Apr 20. pii: 10.1007/s10620-018-5080.
    >> Share

  338. SAFADI S, Delu AN, Alcorn J, McCarthy D, et al
    Portal Hypertensive Bleeding: A Navel Approach.
    Dig Dis Sci. 2018 Apr 19. pii: 10.1007/s10620-018-5062.
    >> Share

  339. GIANNINI EG, Coppo C, Romana C, Camerini GB, et al
    Long-Term Follow-Up Study of Liver-Related Outcome After Bilio-Pancreatic Diversion in Patients with Initial, Significant Liver Damage.
    Dig Dis Sci. 2018 Apr 9. pii: 10.1007/s10620-018-5052.
    >> Share

  340. GADIPARTHI C, Cholankeril G, Yoo ER, Hu M, et al
    Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Dig Dis Sci. 2018 Apr 2. pii: 10.1007/s10620-018-5032.
    >> Share

    March 2018
  341. PONZETTO A, Vaira D
    Hepatic Encephalopathy and Helicobacter pylori.
    Dig Dis Sci. 2018 Mar 29. pii: 10.1007/s10620-018-5038.
    >> Share

  342. DANIELSEN KV, Wiese S, Hove J, Bendtsen F, et al
    Pronounced Coronary Arteriosclerosis in Cirrhosis: Influence on Cardiac Function and Survival?
    Dig Dis Sci. 2018 Mar 8. pii: 10.1007/s10620-018-5006.
    >> Share

  343. ZOU WY, El-Serag HB, Sada YH, Temple SL, et al
    Determinants and Outcomes of Hospice Utilization Among Patients with Advance-Staged Hepatocellular Carcinoma in a Veteran Affairs Population.
    Dig Dis Sci. 2018 Mar 5. pii: 10.1007/s10620-018-4989.
    >> Share

  344. GREMIDA A, Paleti S, Perez ET, McCarthy D, et al
    Hemolysis in Alcoholic Liver Disease: Zieve's Syndrome.
    Dig Dis Sci. 2018;63:601-604.
    >> Share

    February 2018
  345. VARDI I, Barel O, Sperber M, Schvimer M, et al
    Genetic and Structural Analysis of a SKIV2L Mutation Causing Tricho-hepato-enteric Syndrome.
    Dig Dis Sci. 2018 Feb 26. pii: 10.1007/s10620-018-4983.
    >> Share

  346. KOUNTOURAS J, Polyzos SA, Katsinelos P, Anastasiadis S, et al
    Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology.
    Dig Dis Sci. 2018 Feb 21. pii: 10.1007/s10620-018-4911.
    >> Share

  347. WEI M, Ford J, Li Q, Jeong D, et al
    Hospital Cirrhosis Volume and Readmission in Patients with Cirrhosis in California.
    Dig Dis Sci. 2018 Feb 19. pii: 10.1007/s10620-018-4964.
    >> Share

  348. MAIER MM, Zhou XH, Chapko M, Leipertz SL, et al
    Hepatitis C Cure Is Associated with Decreased Healthcare Costs in Cirrhotics in Retrospective Veterans Affairs Cohort.
    Dig Dis Sci. 2018 Feb 16. pii: 10.1007/s10620-018-4956.
    >> Share

  349. KIM JH, Sinn DH, Lee JH, Hyun D, et al
    Novel Albumin-Bilirubin Grade-Based Risk Prediction Model for Patients with Hepatocellular Carcinoma Undergoing Chemoembolization.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4934.
    >> Share

  350. YU Z, Wang R, Chen F, Wang J, et al
    Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
    Dig Dis Sci. 2018 Feb 13. pii: 10.1007/s10620-018-4961.
    >> Share

  351. MINDIKOGLU AL, Opekun AR, Mitch WE, Magder LS, et al
    Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis.
    Dig Dis Sci. 2018 Feb 1. pii: 10.1007/s10620-017-4897.
    >> Share

  352. ESCORSELL A, Garcia-Pagan JC, Bosch J
    Esophageal Stents for Acute Variceal Bleeding: Expanding the Possibilities.
    Dig Dis Sci. 2018;63:275-276.
    >> Share

  353. MAIWALL R, Jamwal KD, Bhardwaj A, Bhadoria AS, et al
    SX-Ella Stent Danis Effectively Controls Refractory Variceal Bleed in Patients with Acute-on-Chronic Liver Failure.
    Dig Dis Sci. 2018;63:493-501.
    >> Share

    January 2018
  354. TORRES-MENA JE, Salazar-Villegas KN, Sanchez-Rodriguez R, Lopez-Gabino B, et al
    Aldo-Keto Reductases as Early Biomarkers of Hepatocellular Carcinoma: A Comparison Between Animal Models and Human HCC.
    Dig Dis Sci. 2018 Jan 30. pii: 10.1007/s10620-018-4943.
    >> Share

  355. BAFFY G
    Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2018 Jan 22. pii: 10.1007/s10620-017-4903.
    >> Share

  356. NG PKS, Lau CPY, Lam EKY, Li SSK, et al
    Hypermethylation of NF-kappaB-Activating Protein-Like (NKAPL) Promoter in Hepatocellular Carcinoma Suppresses Its Expression and Predicts a Poor Prognosis.
    Dig Dis Sci. 2018 Jan 20. pii: 10.1007/s10620-018-4929.
    >> Share

  357. BENBOW JH, Elam AD, Bossi KL, Massengill DL, et al
    Analysis of Plasma Tenascin-C in Post-HCV Cirrhosis: A Prospective Study.
    Dig Dis Sci. 2018 Jan 12. pii: 10.1007/s10620-017-4860.
    >> Share

  358. BURROUGHS TK, Wade JB, Ellwood MS, Fagan A, et al
    Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Dig Dis Sci. 2018 Jan 8. pii: 10.1007/s10620-017-4894.
    >> Share

  359. LI S, He X, Dang L, Xu F, et al
    Efficacy of (125)I Versus Non-(125)I Combined with Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma with Obstructive Jaundice.
    Dig Dis Sci. 2018 Jan 5. pii: 10.1007/s10620-017-4899.
    >> Share

    December 2017
  360. CHOE WH, Kim JH, Park JH, Kim HU, et al
    Endoscopic Submucosal Dissection of Early Gastric Cancer in Patients with Liver Cirrhosis.
    Dig Dis Sci. 2017 Dec 27. pii: 10.1007/s10620-017-4814.
    >> Share

  361. JONES PD, Diaz C, Wang D, Gonzalez-Diaz J, et al
    The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Dig Dis Sci. 2017 Dec 23. pii: 10.1007/s10620-017-4869.
    >> Share

  362. ZHANG X, Li C, Wen T, Peng W, et al
    Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
    Dig Dis Sci. 2017 Dec 14. pii: 10.1007/s10620-017-4861.
    >> Share

  363. LIN M, Chang Y, Xie F, Shi Y, et al
    ASPP2 Inhibits the Profibrotic Effects of Transforming Growth Factor-beta1 in Hepatic Stellate Cells by Reducing Autophagy.
    Dig Dis Sci. 2017 Dec 2. pii: 10.1007/s10620-017-4816.
    >> Share

  364. SUK KT, Kim MY, Jeong SW, Jang JY, et al
    Impact of Bacterial Translocation on Hepatopulmonary Syndrome: A Prospective Observational Study.
    Dig Dis Sci. 2017 Dec 1. pii: 10.1007/s10620-017-4868.
    >> Share

  365. AHMAD J, Odin JA, Hayashi PH, Chalasani N, et al
    Identification and Characterization of Fenofibrate-Induced Liver Injury.
    Dig Dis Sci. 2017;62:3596-3604.
    >> Share

  366. YANG HJ, Chang Y, Park SK, Jung YS, et al
    Nonalcoholic Fatty Liver Disease Is Associated with Increased Risk of Reflux Esophagitis.
    Dig Dis Sci. 2017;62:3605-3613.
    >> Share

  367. GLASS LM, Waljee AK, McCurdy H, Su GL, et al
    Specialty Care Access Network-Extension of Community Healthcare Outcomes Model Program for Liver Disease Improves Specialty Care Access.
    Dig Dis Sci. 2017;62:3344-3349.
    >> Share

    November 2017
  368. LIU H, Hu J, Pan H, Luo D, et al
    CSN5 Promotes Hepatocellular Carcinoma Progression by SCARA5 Inhibition Through Suppressing beta-Catenin Ubiquitination.
    Dig Dis Sci. 2017 Nov 30. pii: 10.1007/s10620-017-4855.
    >> Share

  369. GANDINI R, Merolla S, Chegai F, Abrignani S, et al
    Trans-splenic Embolization Plus Partial Splenic Embolization for Management of Variceal Bleeding Due to Left-Sided Portal Hypertension.
    Dig Dis Sci. 2017 Nov 28. pii: 10.1007/s10620-017-4863.
    >> Share

  370. PRIVITERA G, Spadaro L, Marchisello S, Fede G, et al
    Abnormalities of Lipoprotein Levels in Liver Cirrhosis: Clinical Relevance.
    Dig Dis Sci. 2017 Nov 25. pii: 10.1007/s10620-017-4862.
    >> Share

  371. ZHOU C, Sun Y, Guo S, Chen X, et al
    Wls Expression Correlates with Tumor Differentiation and TNM Stage in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 10. doi: 10.1007/s10620-017-4823.
    >> Share

  372. TITAN AL, Devereaux K, Louie JD, Poultsides GA, et al
    Clinical Trigonometry: Right Hepatic Trisegmentectomy After Radiation Trisegmentectomy for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4797.
    >> Share

  373. WIJARNPREECHA K, Chesdachai S, Thongprayoon C, Jaruvongvanich V, et al
    Association of Helicobacter pylori with the Risk of Hepatic Encephalopathy.
    Dig Dis Sci. 2017 Nov 8. doi: 10.1007/s10620-017-4834.
    >> Share

  374. HUANG CS, Zhai JM, Zhu XX, Cai JP, et al
    BTG2 Is Down-Regulated and Inhibits Cancer Stem Cell-Like Features of Side Population Cells in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4829.
    >> Share

  375. CULLARO G, Kim G, Pereira MR, Brown RS Jr, et al
    Ascites Neutrophil Gelatinase-Associated Lipocalin Identifies Spontaneous Bacterial Peritonitis and Predicts Mortality in Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2017 Nov 2. doi: 10.1007/s10620-017-4804.
    >> Share

  376. TANEJA S, Borkakoty A, Rathi S, Kumar V, et al
    Assessment of Liver Fibrosis by Transient Elastography Should Be Done After Hemodialysis in End Stage Renal Disease Patients with Liver Disease.
    Dig Dis Sci. 2017;62:3186-3192.
    >> Share

  377. CATRON TD, Smallfield GB, Kang L, Sterling RK, et al
    Endoscopic Cyanoacrylate Injection with Post-injection Audible Doppler Assessment of Gastric Varices: A Single-Institution Experience.
    Dig Dis Sci. 2017;62:3091-3099.
    >> Share

    October 2017
  378. LU Z, Lin Y, Peng B, Bao Z, et al
    Hydrogen-Rich Saline Ameliorates Hepatic Ischemia-Reperfusion Injury Through Regulation of Endoplasmic Reticulum Stress and Apoptosis.
    Dig Dis Sci. 2017 Oct 30. doi: 10.1007/s10620-017-4811.
    >> Share

  379. MUDAMBI K, Berquist W
    "Blueberry Muffin" Rash and Neonatal Cholestatic Liver Failure.
    Dig Dis Sci. 2017 Oct 25. doi: 10.1007/s10620-017-4810.
    >> Share

  380. WU W, Liu S, Liang Y, Zhou Z, et al
    Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells.
    Dig Dis Sci. 2017 Oct 17. doi: 10.1007/s10620-017-4798.
    >> Share

  381. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Correction to: Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Oct 13. doi: 10.1007/s10620-017-4785.
    >> Share

  382. KRUGER AJ, Mumtaz K, Anaizi A, Modi RM, et al
    Cirrhosis Is Associated with Increased Mortality in Patients with Diverticulitis: A Nationwide Cross-Sectional Study.
    Dig Dis Sci. 2017 Oct 6. doi: 10.1007/s10620-017-4782.
    >> Share

  383. OH IS, Sinn DH, Kang TW, Lee MW, et al
    Liver Function Assessment Using Albumin-Bilirubin Grade for Patients with Very Early-Stage Hepatocellular Carcinoma Treated with Radiofrequency Ablation.
    Dig Dis Sci. 2017 Oct 5. doi: 10.1007/s10620-017-4775.
    >> Share

  384. REDMAN JS, Natarajan Y, Hou JK, Wang J, et al
    Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing.
    Dig Dis Sci. 2017;62:2713-2718.
    >> Share

  385. KHOURY T, Asombang AW, Berzin TM, Cohen J, et al
    The Clinical Implications of Fatty Pancreas: A Concise Review.
    Dig Dis Sci. 2017;62:2658-2667.
    >> Share

    September 2017
  386. XING J, Spradling PR, Moorman AC, Holmberg SD, et al
    A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis C.
    Dig Dis Sci. 2017 Sep 30. doi: 10.1007/s10620-017-4762.
    >> Share

  387. PARIKH ND, Fu S, Rao H, Yang M, et al
    Risk Assessment of Hepatocellular Carcinoma in Patients with Hepatitis C in China and the USA.
    Dig Dis Sci. 2017 Sep 25. doi: 10.1007/s10620-017-4776.
    >> Share

  388. ROSEN E, Bakshi N, Watters A, Rosen HR, et al
    Hepatic Complications of Anorexia Nervosa.
    Dig Dis Sci. 2017 Sep 20. doi: 10.1007/s10620-017-4766.
    >> Share

  389. ZHANG S, Xiao J, Chai Y, Du YY, et al
    LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152.
    Dig Dis Sci. 2017 Sep 18. doi: 10.1007/s10620-017-4759.
    >> Share

  390. HOSSAIN N, Puchakayala B, Kanwar P, Verma S, et al
    Risk Factor Analysis Between Newly Screened and Established Hepatitis C in GI and Hepatology Clinics.
    Dig Dis Sci. 2017 Sep 14. doi: 10.1007/s10620-017-4754.
    >> Share

  391. IKEDA K, Kawamura Y, Kobayashi M, Kominami Y, et al
    Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Sep 7. doi: 10.1007/s10620-017-4739.
    >> Share

  392. OGISO H, Ito H, Kanbe A, Ando T, et al
    The Inhibition of Indoleamine 2,3-Dioxygenase Accelerates Early Liver Regeneration in Mice After Partial Hepatectomy.
    Dig Dis Sci. 2017;62:2386-2396.
    >> Share

  393. LUTZ P, Goeser F, Kaczmarek DJ, Schlabe S, et al
    Relative Ascites Polymorphonuclear Cell Count Indicates Bacterascites and Risk of Spontaneous Bacterial Peritonitis.
    Dig Dis Sci. 2017;62:2558-2568.
    >> Share

  394. DE LEDINGHEN V, Hiriart JB, Vergniol J, Merrouche W, et al
    Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan((R)): A Comparative Study with the M Probe and Liver Biopsy.
    Dig Dis Sci. 2017;62:2569-2577.
    >> Share

    August 2017
  395. CHEDID MF
    Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.
    Dig Dis Sci. 2017 Aug 24. doi: 10.1007/s10620-017-4724.
    >> Share

  396. CHENG L, Wang H, Han S
    MiR-3910 Promotes the Growth and Migration of Cancer Cells in the Progression of Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 19. doi: 10.1007/s10620-017-4670.
    >> Share

  397. KIM JK, Kim HD, Jun MJ, Yun SC, et al
    Tumor Volume Doubling Time as a Dynamic Prognostic Marker for Patients with Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4708.
    >> Share

  398. XU H, Xiong J, Xu J, Li S, et al
    Mosapride Stabilizes Intestinal Microbiota to Reduce Bacterial Translocation and Endotoxemia in CCl4-Induced Cirrhotic Rats.
    Dig Dis Sci. 2017 Aug 16. doi: 10.1007/s10620-017-4704.
    >> Share

  399. GREMIDA A, Al-Taee A, Alcorn J, McCarthy D, et al
    Hepatic Dysfunction in Renal Cell Carcinoma: Not What You Think?
    Dig Dis Sci. 2017 Aug 7. doi: 10.1007/s10620-017-4706.
    >> Share

  400. LEE HW, Kim BK, Kim SU, Park JY, et al
    Prevalence and Predictors of Significant Fibrosis Among Subjects with Transient Elastography-Defined Nonalcoholic Fatty Liver Disease.
    Dig Dis Sci. 2017;62:2150-2158.
    >> Share

  401. JIMENEZ JV, Carrillo-Perez DL, Rosado-Canto R, Garcia-Juarez I, et al
    Electrolyte and Acid-Base Disturbances in End-Stage Liver Disease: A Physiopathological Approach.
    Dig Dis Sci. 2017;62:1855-1871.
    >> Share

    July 2017
  402. CHOLANKERIL G, Wong RJ, Hu M, Perumpail RB, et al
    Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4684.
    >> Share

  403. EUN HS, Lee BS, Kwon IS, Yun GY, et al
    Advantages of Laparoscopic Radiofrequency Ablation Over Percutaneous Radiofrequency Ablation in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 Jul 25. doi: 10.1007/s10620-017-4688.
    >> Share

  404. SARTINI A, Gitto S, Villa E
    Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients?
    Dig Dis Sci. 2017 Jul 4. doi: 10.1007/s10620-017-4665.
    >> Share

    June 2017
  405. YANG C, Gomez A, Haldipur A, Berquist W, et al
    Growing Concerns: A 3-Year-Old Girl with Multiple Hepatic Masses and Gastrointestinal Bleeding.
    Dig Dis Sci. 2017 Jun 23. doi: 10.1007/s10620-017-4644.
    >> Share

  406. FITTIPALDI S, Vasuri F, Bonora S, Degiovanni A, et al
    miRNA Signature of Hepatocellular Carcinoma Vascularization: How the Controls Can Influence the Signature.
    Dig Dis Sci. 2017 Jun 21. doi: 10.1007/s10620-017-4654.
    >> Share

  407. WU S, Yang C, Xu N, Wang L, et al
    The Protective Effects of Helix B Surface Peptide on Experimental Acute Liver Injury Induced by Carbon Tetrachloride.
    Dig Dis Sci. 2017;62:1537-1549.
    >> Share

  408. SAFADI S, Mohamed AM, Altamimi BA, Strickland RG, et al
    Decompensated Liver Disease in a Patient with Neurocysticercosis.
    Dig Dis Sci. 2017;62:1443-1447.
    >> Share

    May 2017
  409. PANTHAM G, Post A, Venkat D, Einstadter D, et al
    A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis.
    Dig Dis Sci. 2017 May 30. doi: 10.1007/s10620-017-4630.
    >> Share

  410. WALLACE MC, Huang Y, Preen DB, Garas G, et al
    HKLC Triages More Hepatocellular Carcinoma Patients to Curative Therapies Compared to BCLC and Is Associated with Better Survival.
    Dig Dis Sci. 2017 May 25. doi: 10.1007/s10620-017-4622.
    >> Share

  411. DE MATTEIS S, Granato AM, Napolitano R, Molinari C, et al
    Interplay Between SIRT-3, Metabolism and Its Tumor Suppressor Role in Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 19. doi: 10.1007/s10620-017-4615.
    >> Share

  412. ROGAL SS, McCarthy R, Reid A, Rodriguez KL, et al
    Primary Care and Hepatology Provider-Perceived Barriers to and Facilitators of Hepatitis C Treatment Candidacy and Adherence.
    Dig Dis Sci. 2017 May 18. doi: 10.1007/s10620-017-4608.
    >> Share

  413. TAVAKOLI H, Robinson A, Liu B, Bhuket T, et al
    Cirrhosis Patients with Nonalcoholic Steatohepatitis Are Significantly Less Likely to Receive Surveillance for Hepatocellular Carcinoma.
    Dig Dis Sci. 2017 May 4. doi: 10.1007/s10620-017-4595.
    >> Share

  414. DOYCHEVA I, Watt KD, Rifai G, Abou Mrad R, et al
    Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.
    Dig Dis Sci. 2017;62:1373-1380.
    >> Share

  415. GAIDOS JKJ, Fuchs M
    Increased Prevalence of NAFLD in IBD Patients.
    Dig Dis Sci. 2017;62:1362.
    >> Share

    April 2017
  416. HAMARNEH SR, Kim BM, Kaliannan K, Morrison SA, et al
    Intestinal Alkaline Phosphatase Attenuates Alcohol-Induced Hepatosteatosis in Mice.
    Dig Dis Sci. 2017 Apr 19. doi: 10.1007/s10620-017-4576.
    >> Share

  417. YOSHIDA T, Akiba J, Matsui T, Nakamura K, et al
    Pigment Epithelium-Derived Factor (PEDF) Prevents Hepatic Fat Storage, Inflammation, and Fibrosis in Dietary Steatohepatitis of Mice.
    Dig Dis Sci. 2017 Apr 1. doi: 10.1007/s10620-017-4550.
    >> Share

  418. TESCHKE R, Eickhoff A
    Suspected Liver Injury and the Dilemma of Causality.
    Dig Dis Sci. 2017;62:1095-1098.
    >> Share

    March 2017
  419. CARR RM, Patel A, Bownik H, Oranu A, et al
    Intestinal Inflammation Does Not Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4495.
    >> Share

  420. KOHLI DR, Vachhani R, Shah TU, BouHaidar DS, et al
    Diagnostic Accuracy of Laboratory Tests and Diagnostic Imaging in Detecting Biliary Strictures After Liver Transplantation.
    Dig Dis Sci. 2017 Mar 6. doi: 10.1007/s10620-017-4515.
    >> Share

  421. O'LEARY JG, Wong F, Reddy KR, Garcia-Tsao G, et al
    Gender-Specific Differences in Baseline, Peak, and Delta Serum Creatinine: The NACSELD Experience.
    Dig Dis Sci. 2017;62:768-776.
    >> Share

  422. HEIDEMANN L, Law J, Fontana RJ
    A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury.
    Dig Dis Sci. 2017;62:615-625.
    >> Share

    February 2017
  423. LIN MX, Ye JY, Tian WS, Xu M, et al
    Risk Factors for Bile Duct Injury After Percutaneous Thermal Ablation of Malignant Liver Tumors: A Retrospective Case-Control Study.
    Dig Dis Sci. 2017 Feb 15. doi: 10.1007/s10620-016-4312.
    >> Share

  424. BALAKRISHNAN M, El-Serag HB, Kanwal F, Thrift AP, et al
    Shiftwork Is Not Associated with Increased Risk of NAFLD: Findings from the National Health and Nutrition Examination Survey.
    Dig Dis Sci. 2017;62:526-533.
    >> Share

  425. KUO SZ, Haftek M, Lai JC
    Factors Associated with Medication Non-adherence in Patients with End-Stage Liver Disease.
    Dig Dis Sci. 2017;62:543-549.
    >> Share

    January 2017
  426. ZHAO D, Luo Y, Xia Y, Zhang JJ, et al
    MicroRNA-19b Expression in Human Biliary Atresia Specimens and Its Role in BA-Related Fibrosis.
    Dig Dis Sci. 2017 Jan 12. doi: 10.1007/s10620-016-4411.
    >> Share

  427. LEIBOVICI-WEISSMAN Y, Mor E, Leshno M, Shlomai A, et al
    Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation.
    Dig Dis Sci. 2017 Jan 4. doi: 10.1007/s10620-016-4423.
    >> Share

  428. SRIDHAR A, Cwiak CA, Kaunitz AM, Allen RH, et al
    Contraceptive Considerations for Women with Gastrointestinal Disorders.
    Dig Dis Sci. 2017;62:54-63.
    >> Share

    November 2016
  429. DONOVAN RJ, Choi C, Ali A, Heuman DM, et al
    Perioperative Cardiovascular Evaluation for Orthotopic Liver Transplantation.
    Dig Dis Sci. 2016.
    >> Share

    October 2016
  430. HA TH, Kim BG, Jeong D, Oh S, et al
    Alcoholic Liver Disease Is Associated with an Increased Risk of Gastric Cancer.
    Dig Dis Sci. 2016.
    >> Share

    August 2016
  431. SOTIROPOULOS GC, Vernadakis S, Paul A, Hoyer DP, et al
    Single-Center Experience on Liver Transplantation for Model for End-Stage Liver Disease Score 40 Patients.
    Dig Dis Sci. 2016.
    >> Share

    July 2016
  432. HEGADE VS, Khanna A, Walker LJ, Wong LL, et al
    Long-Term Fenofibrate Treatment in Primary Biliary Cholangitis Improves Biochemistry but Not the UK-PBC Risk Score.
    Dig Dis Sci. 2016.
    >> Share

    March 2016
  433. JARUVONGVANICH V, Sanguankeo A, Upala S
    Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2016.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016